FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Haffner

Research Profile

Disorders

Concepts & Ideas

Risk Factors

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Carlos Lorenzo; Marian J Rewers; Lynne E Wagenknecht; Anthony J Hanley; Sara Hartnett; Andrew J Karter; Steven M Haffner
Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study.
Carlos Lorenzo; Marian Rewers; A J Hanley; Steven M Haffner
The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study.
Yee Weng Wong; Thomas Giles; Steven M Haffner; Adrian F Hernandez; Henry Krum; Lawrence A Leiter; Felipe A Martinez; Theodore Mazzone; John J V McMurray; Guy E H M Rutten; Eberhard Standl; Jie Lena Sun; Laine Thomas; Gianni Tognoni; Robert M Califf
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Haffner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Carlos Lorenzo; Marian J Rewers; Lynne E Wagenknecht; Anthony J Hanley; Sara Hartnett; Andrew J Karter; Steven M Haffner
Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study.
The Journal of clinical endocrinology and metabolism 2013;98(4):1622-30.
2013: Carlos Lorenzo; Marian Rewers; A J Hanley; Steven M Haffner
The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study.
Diabetologia 2013;56(4):746-57.
2013: Yee Weng Wong; Thomas Giles; Steven M Haffner; Adrian F Hernandez; Henry Krum; Lawrence A Leiter; Felipe A Martinez; Theodore Mazzone; John J V McMurray; Guy E H M Rutten; Eberhard Standl; Jie Lena Sun; Laine Thomas; Gianni Tognoni; Robert M Califf
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.
Circulation. Heart failure 2013;6(2):203-10.
2013: Mirjam V Faulenbach; Wilfred Y Fujimoto; Julia H Goedecke; Steven M Haffner; Steven E Kahn; Donna L Leonetti; Carlos Lorenzo; Marguerite J McNeely; Kristina M Utzschneider; Lorena A Wright; Edward J Boyko
Impact of differences in glucose tolerance on the prevalence of a negative insulinogenic index.
Journal of diabetes and its complications 2013;27(2):158-61.
2013: C C Lee; Carlos Lorenzo; J M Norris; N C Olson; M J Rewers; D Stefanovski; L E Wagenknecht; A Festa; M O Goodarzi; Steven M Haffner; Anthony J G Hanley
The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS).
Diabetologia 2013;56(1):112-20.
2013: S Sandy An; W Mark Brown; Y-D Ida Chen; Xiuqing Guo; Steven M Haffner; Anthony J G Hanley; Carl D Langefeld; Jill M Norris; Nicholette D Palmer; Jerome I Rotter; Lynne E Wagenknecht; Julie T Ziegler; Donald W Bowden
Estimating the contributions of rare and common genetic variations and clinical measures to a model trait: adiponectin.
Genetic epidemiology 2013;37(1):13-24.
2012: Hans-Henrik Parving; Frederik Persson; Marc A Pfeffer; Alexia Richard; Scott D Solomon; Zhihua Xiang; Barry M Brenner; Patrick Brunel; Nish Chaturvedi; Dick de Zeeuw; Akshay S Desai; Steven M Haffner; John J V McMurray; Maria Nicolaides
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
The New England journal of medicine 2012;367(23):2204-13.
2012: S Sandy An; Donald W Bowden; W Mark Brown; Y-D Ida Chen; Xiuqing Guo; Steven M Haffner; Anthony J G Hanley; Carl D Langefeld; Jill M Norris; Jerome I Rotter; Lynne E Wagenknecht; Julie T Ziegler; Nicholette D Palmer
Association between ADIPOQ SNPs with plasma adiponectin and glucose homeostasis and adiposity phenotypes in the IRAS Family Study.
Molecular genetics and metabolism 2012;107(4):721-8.
2012: Carlos Lorenzo; K Williams; Steven M Haffner
Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study.
Diabetic medicine : a journal of the British Diabetic Association 2012;29(8):e151-8.
2012: Carlos Lorenzo; Helen Hazuda; Steven M Haffner
Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart Study.
The Journal of clinical endocrinology and metabolism 2012;97(3):793-9.
2012: Kendra A Young; Lynne E Wagenknecht; Tasha E Fingerlin; Steven M Haffner; Carl D Langefeld; Carlos Lorenzo; Jill M Norris
Exploring differences in adiposity in two U.S. Hispanic populations of Mexican origin using social, behavioral, physiologic and genetic markers: the IRAS Family Study.
Ethnicity & disease 2012;22(1):65-71.
2011: R C Loopstra-Masters; Carlos Lorenzo; L E Wagenknecht; Steven M Haffner; Anthony J G Hanley
Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).
Diabetologia 2011;54(12):3047-54.
2011: John M Lachin; Gitanjali Paul; Giancarlo Viberti; Bernard Zinman; R Paul Aftring; Steven M Haffner; William H Herman; Rury R Holman; Steven E Kahn; Barbara G Kravitz
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(5):1032-40.
2011: R C Loopstra-Masters; A D Liese; Steven M Haffner; L E Wagenknecht; Anthony J G Hanley
Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function.
Diabetologia 2011;54(2):320-8.
2011: Rebecca L Sedjo; Ralph B D'Agostino; Dennis Ahnen; Theodore R Levin; Steven M Haffner; Janet A Tooze; Tim E Byers
Lack of association between insulin sensitivity and colorectal adenoma risk.
Nutrition and cancer 2011;63(1):6-11.
2010: Carlos Lorenzo; Steven M Haffner; Alena Stancáková; M Laakso
Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals.
The Journal of clinical endocrinology and metabolism 2010;95(11):5082-90.
2010: Corinne D Engelman; Kristin J Meyers; Julie T Ziegler; Kent D Taylor; Nicholette D Palmer; Steven M Haffner; Tasha E Fingerlin; Lynne E Wagenknecht; Jerome I Rotter; Donald W Bowden; Carl D Langefeld; Jill M Norris
Genome-wide association study of vitamin D concentrations in Hispanic Americans: the IRAS family study.
The Journal of steroid biochemistry and molecular biology 2010;122(4):186-92.
2010: Rachel C Masters; Angela D Liese; Steven M Haffner; Lynne E Wagenknecht; Anthony J Hanley
Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma.
The Journal of nutrition 2010;140(3):587-94.
2010: Melissa R Miller; Weiming Zhang; Scott P Sibbel; Carl D Langefeld; Donald W Bowden; Steven M Haffner; Richard N Bergman; Jill M Norris; Tasha E Fingerlin
Variant in the 3' region of the IkappaBalpha gene associated with insulin resistance in Hispanic Americans: The IRAS Family Study.
Obesity (Silver Spring, Md.) 2010;18(3):555-62.
2010: Nicholette D Palmer; Carl D Langefeld; J T Ziegler; F Hsu; Steven M Haffner; Tasha E Fingerlin; Jill M Norris; Y I Chen; Stephen S Rich; T Haritunians; K D Taylor; Richard N Bergman; Jerome I Rotter; Donald W Bowden
Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study.
Diabetologia 2010;53(2):281-9.
2010: Carlos Lorenzo; Steven M Haffner
Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study.
Diabetes care 2010;33(2):335-7.
2010: Bernard Zinman; Steven M Haffner; William H Herman; Rury R Holman; John M Lachin; Barbara G Kravitz; Gitanjali Paul; Nigel P Jones; R Paul Aftring; Giancarlo Viberti; Steven E Kahn
Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2010;95(1):134-42.
2010: Carlos Lorenzo; Lynne E Wagenknecht; Ralph B D'Agostino; Marian Rewers; Andrew J Karter; Steven M Haffner
Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study.
Diabetes care 2010;33(1):67-72.
2010: Steven E Kahn; Steven M Haffner; Giancarlo Viberti; William H Herman; John M Lachin; Barbara G Kravitz; Dahong Yu; Gitanjali Paul; Rury R Holman; Bernard Zinman
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).
Diabetes care 2010;33(1):177-83.
2009: M Angelyn Bethel; P Deedwania; N S Levitt; O Schmitz; A Huntsman-Labed; Robert M Califf; Steven M Haffner; P Diem
Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.
Diabetic medicine : a journal of the British Diabetic Association 2009;26(12):1204-11.
2009: Carlos Lorenzo; KoKo Aung; Michael P Stern; Steven M Haffner
Pulse pressure, prehypertension, and mortality: the San Antonio heart study.
American journal of hypertension 2009;22(11):1219-26.
2009: Carlos Lorenzo; Ken Williams; Michael P Stern; Steven M Haffner
Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study.
Metabolism: clinical and experimental 2009;58(11):1530-5.
2009: Anthony J G Hanley; L E Wagenknecht; J M Norris; Michael Bryer-Ash; Y I Chen; A M Anderson; R Bergman; Steven M Haffner
Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study.
Diabetologia 2009;52(10):2079-86.
2009: David R Mullican; Carlos Lorenzo; Steven M Haffner
Is prehypertension a risk factor for the development of type 2 diabetes?
Diabetes care 2009;32(10):1870-2.
2009: Jill M Norris; Carl D Langefeld; Matthew E Talbert; Maria R Wing; Talin Haritunians; Tasha E Fingerlin; Anthony J G Hanley; Julie T Ziegler; Kent D Taylor; Steven M Haffner; Yii-Der I Chen; Donald W Bowden; Lynne E Wagenknecht
Genome-wide association study and follow-up analysis of adiposity traits in Hispanic Americans: the IRAS Family Study.
Obesity (Silver Spring, Md.) 2009;17(10):1932-41.
2009: Kendra A Young; Corinne D Engelman; Carl D Langefeld; Kristen G Hairston; Steven M Haffner; Michael Bryer-Ash; Jill M Norris
Association of plasma vitamin D levels with adiposity in Hispanic and African Americans.
The Journal of clinical endocrinology and metabolism 2009;94(9):3306-13.
2009: Kristen G Hairston; Ann L Scherzinger; Capri Foy; Anthony J G Hanley; Orita McCorkle; Steven M Haffner; Jill M Norris; Michael Bryer-Ash; Lynne E Wagenknecht
Five-year change in visceral adipose tissue quantity in a minority cohort: the Insulin Resistance Atherosclerosis Study (IRAS) family study.
Diabetes care 2009;32(8):1553-5.
2009: Angela D Liese; Michele Nichols; Xuezheng Sun; Ralph B D'Agostino; Steven M Haffner
Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the insulin resistance atherosclerosis study.
Diabetes care 2009;32(8):1434-6.
2009: Kimberly J Schmitz; Halcyon Skinner; Leonelo E Bautista; Tasha E Fingerlin; Carl D Langefeld; Pamela J Hicks; Steven M Haffner; Michael Bryer-Ash; Lynne E Wagenknecht; Donald W Bowden; Jill M Norris; Corinne D Engelman
Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans.
American journal of hypertension 2009;22(8):867-70.
2009: Matthew E Talbert; Carl D Langefeld; Julie T Ziegler; Steven M Haffner; Jill M Norris; Donald W Bowden
INSIG2 SNPs associated with obesity and glucose homeostasis traits in Hispanics: the IRAS Family Study.
Obesity (Silver Spring, Md.) 2009;17(8):1554-62.
2009: Hans-Henrik Parving; Barry M Brenner; John J V McMurray; Dick de Zeeuw; Steven M Haffner; Scott D Solomon; Nish Chaturvedi; Marc A Pfeffer
Dual renin-angiotensin system blockade and kidney disease.
Journal of the American College of Cardiology 2009;54(3):278-9; author reply 279-80.
2009: S S Rich; M O Goodarzi; N D Palmer; Carl D Langefeld; J Ziegler; Steven M Haffner; M Bryer-Ash; J M Norris; K D Taylor; T Haritunians; Jerome I Rotter; Y-D I Chen; L E Wagenknecht; D W Bowden; R N Bergman
A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS).
Diabetologia 2009;52(7):1326-33.
2009: Carlos Lorenzo; Subrata D Nath; Anthony J G Hanley; Hanna Abboud; Jonathan Gelfond; Steven M Haffner
Risk of type 2 diabetes among individuals with high and low glomerular filtration rates.
Diabetologia 2009;52(7):1290-7.
2009: Lynne E Wagenknecht; Ann L Scherzinger; Elizabeth R Stamm; Anthony J G Hanley; Jill M Norris; Yii-Der I Chen; Michael Bryer-Ash; Steven M Haffner; Jerome I Rotter
Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort.
Obesity (Silver Spring, Md.) 2009;17(6):1240-6.
2009: Beth S Sutton; Nicholette D Palmer; Carl D Langefeld; Bingzhong Xue; Alexandria Proctor; Julie T Ziegler; Steven M Haffner; Jill M Norris; Donald W Bowden
Association of SSTR2 polymorphisms and glucose homeostasis phenotypes: the Insulin Resistance Atherosclerosis Family Study.
Diabetes 2009;58(6):1457-62.
2009: Maria R Wing; Julie Ziegler; Carl D Langefeld; Maggie C Y Ng; Steven M Haffner; Jill M Norris; Mark O Goodarzi; Donald W Bowden
Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study.
Human genetics 2009;125(5-6):615-26.
2009: Arijit Dasgupta; Steven R Steinhubl; Deepak L Bhatt; Peter B Berger; Mingyuan Shao; Koon-Hou Mak; Keith A A Fox; Gilles Montalescot; Michael A Weber; Steven M Haffner; Alexios P Dimas; Philippe Gabriel STEG; Eric J Topol
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial).
The American journal of cardiology 2009;103(10):1359-63.
2009: Deborah A Beihl; Angela D Liese; Steven M Haffner
Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort.
Annals of epidemiology 2009;19(5):351-7.
2009: Susan Sam; Steven M Haffner; Michael H Davidson; Ralph B D'Agostino; Steven Feinstein; George T Kondos; Alfonso Perez; Theodore Mazzone
Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes.
Diabetes care 2009;32(5):932-7.
2009: Alena Stancáková; Martin Javorsky; Tiina Kuulasmaa; Steven M Haffner; Johanna Kuusisto; Markku Laakso
Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men.
Diabetes 2009;58(5):1212-21.
2009: Meredith F MacKay; Steven M Haffner; Lynne E Wagenknecht; Ralph B D'Agostino; Anthony J G Hanley
Prediction of type 2 diabetes using alternate anthropometric measures in a multi-ethnic cohort: the insulin resistance atherosclerosis study.
Diabetes care 2009;32(5):956-8.
2009: Hans-Henrik Parving; Barry M Brenner; John J V McMurray; Dick de Zeeuw; Steven M Haffner; Scott D Solomon; Nish Chaturvedi; Mathieu Ghadanfar; Nicole Weissbach; Zhihua Xiang; Juergen Armbrecht; Marc A Pfeffer
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(5):1663-71.
2009: Koon-Hou Mak; Deepak L Bhatt; Mingyuan Shao; Steven M Haffner; Christian W Hamm; Graeme J Hankey; S Claiborne Johnston; Gilles Montalescot; Philippe Gabriel STEG; Steven R Steinhubl; Keith A A Fox; Eric J Topol
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease.
European heart journal 2009;30(7):857-65.
2009: Ronald B Goldberg; Marinella Temprosa; Steven M Haffner; Trevor J Orchard; Robert E Ratner; Sarah E Fowler; Kieren Mather; Santica Marcovina; Christopher D Saudek; Margaret J Matulik; David Price
Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.
Diabetes care 2009;32(4):726-32.
2009: Matthew E Talbert; Carl D Langefeld; Julie Ziegler; Josyf C Mychaleckyj; Steven M Haffner; Jill M Norris; Donald W Bowden
Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study.
Human genetics 2009;125(2):153-62.
2009: Janet B McGill; Steven M Haffner; Tomas J Rees; James R Sowers; Andrew M Tershakovec; Michael Weber
Progress and controversies: treating obesity and insulin resistance in the context of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(1):36-41.
2008: Dion H Zappe; James R Sowers; Willa A Hsueh; Steven M Haffner; Prakash C Deedwania; Vivian A Fonseca; Lucy Keeling; Domenic A Sica
Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(12):894-903.
2008: Ken Williams; Andre Tchernof; Kelly J Hunt; Lynne E Wagenknecht; Steven M Haffner; Allan D Sniderman
Diabetes, abdominal adiposity, and atherogenic dyslipoproteinemia in women compared with men.
Diabetes 2008;57(12):3289-96.
2008: Robert M Califf; Mitradev Boolell; Steven M Haffner; M Angelyn Bethel; John McMurray; Anil Duggal; Rury R Holman
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
American heart journal 2008;156(4):623-32.
2008: M Angelyn Bethel; Rury Holman; Steven M Haffner; Robert M Califf; Alice Huntsman-Labed; Tsushung Hua; John McMurray
Determining the most appropriate components for a composite clinical trial outcome.
American heart journal 2008;156(4):633-40.
2008: James L Rosenzweig; Ele Ferrannini; Scott M Grundy; Steven M Haffner; Robert J Heine; Edward S Horton; Ryuzo Kawamori
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline.
The Journal of clinical endocrinology and metabolism 2008;93(10):3671-89.
2008: Mark A Espeland; Judith G Regensteiner; Sarah A Jaramillo; Edward Gregg; William C Knowler; Lynne E Wagenknecht; Judy Bahnson; Steven M Haffner; James Hill; William R Hiatt
Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes study.
Vascular medicine (London, England) 2008;13(3):225-33.
2008: Capri G Foy; Fang-Chi Hsu; Steven M Haffner; Jill M Norris; Jerome I Rotter; Leora F Henkin; Michael Bryer-Ash; Yii-Der I Chen; Lynne E Wagenknecht
Visceral fat and prevalence of hypertension among African Americans and Hispanic Americans: findings from the IRAS family study.
American journal of hypertension 2008;21(8):910-6.
2008: Susan Sam; Steven M Haffner; Michael H Davidson; Ralph B D'Agostino; Steven Feinstein; George T Kondos; Alfonso Perez; Theodore Mazzone
Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.
Diabetes 2008;57(8):2022-7.
2008: Carl Grunfeld; Donald P Kotler; Donna K Arnett; Julian M Falutz; Steven M Haffner; Paul W Hruz; Henry Masur; James B Meigs; Kathleen Mulligan; Peter Reiss; Katherine Samaras
Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.
Circulation 2008;118(2):e20-8.
2008: Jill Crandall; William C Knowler; Steven E Kahn; David Marrero; Jose C Florez; George A Bray; Steven M Haffner; Mary Hoskin; David M Nathan
The prevention of type 2 diabetes.
Nature clinical practice. Endocrinology & metabolism 2008;4(7):382-93.
2008: Andreas Festa; Ken Williams; Anthony J G Hanley; Steven M Haffner
Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
Diabetes 2008;57(6):1638-44.
2008: George A Bray; Kathleen Jablonski; Wilfred Y Fujimoto; Elizabeth Barrett-Connor; Steven M Haffner; Robert L Hanson; James O Hill; Van Hubbard; Andrea Kriska; Elizabeth Stamm; F Xavier Pi-Sunyer
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program.
The American journal of clinical nutrition 2008;87(5):1212-8.
2008: Carlos Lorenzo; Subrata D Nath; Anthony J G Hanley; Hanna Abboud; Steven M Haffner
Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(3):783-9.
2008: Steven E Kahn; Bernard Zinman; John M Lachin; Steven M Haffner; William H Herman; Rury R Holman; Barbara G Kravitz; Dahong Yu; Mark A Heise; R Paul Aftring; Giancarlo Viberti
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).
Diabetes care 2008;31(5):845-51.
2008: Michael Davidson; Peter M Meyer; Steven M Haffner; Steven Feinstein; Ralph D'Agostino; George T Kondos; Alfonso Perez; Zhen Chen; Theodore Mazzone
Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
Circulation 2008;117(16):2123-30.
2008: Nicholette D Palmer; Mark O Goodarzi; Carl D Langefeld; Julie Ziegler; Jill M Norris; Steven M Haffner; Michael Bryer-Ash; Richard N Bergman; Lynne E Wagenknecht; Kent D Taylor; Jerome I Rotter; Donald W Bowden
Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study.
Diabetes 2008;57(4):1093-100.
2008: Mary Helen Black; Tasha E Fingerlin; Hooman Allayee; Weiming Zhang; Anny H Xiang; Enrique Trigo; Jaana Hartiala; Allison B Lehtinen; Steven M Haffner; Richard N Bergman; Richard C McEachin; Siri L Kjos; Jean M Lawrence; Thomas A Buchanan; Richard Watanabe
Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans.
Diabetes 2008;57(4):1048-56.
2008: Richard R Rubin; Yong Ma; David G Marrero; Mark Peyrot; Elizabeth L Barrett-Connor; Steven E Kahn; Steven M Haffner; David W Price; William C Knowler
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.
Diabetes care 2008;31(3):420-6.
2008: Alain G Bertoni; Jeanne M Clark; Patricia Feeney; Susan Z Yanovski; John Bantle; Brenda Montgomery; Monika Maria Safford; William H Herman; Steven M Haffner
Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
Journal of diabetes and its complications 2008;22(1):1-9.
2008: Nicholette D Palmer; Allison B Lehtinen; Carl D Langefeld; Joel K Campbell; Steven M Haffner; Jill M Norris; Richard N Bergman; Mark O Goodarzi; Jerome I Rotter; Donald W Bowden
Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans.
The Journal of clinical endocrinology and metabolism 2008;93(1):304-9.
2007: David P Rose; Steven M Haffner; Jacques Baillargeon
Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.
Endocrine reviews 2007;28(7):763-77.
2007: Carl Grunfeld; David Rimland; Cynthia L Gibert; William G Powderly; Stephen Sidney; Michael G Shlipak; Peter Bacchetti; Rebecca Scherzer; Steven M Haffner; Steven B Heymsfield
Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study.
Journal of acquired immune deficiency syndromes (1999) 2007;46(3):283-90.
2007: Kelly J Hunt; Ken Williams; Helen Hazuda; Michael P Stern; Steven M Haffner
The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study.
Annals of epidemiology 2007;17(11):870-7.
2007: Beverley Balkau; John E Deanfield; Jean-Pierre Després; Jean-Pierre Bassand; Keith A A Fox; Sidney C Smith; Philip Barter; Chee Eng Tan; Luc Van Gaal; Hans-Ulrich Wittchen; Christine Massien; Steven M Haffner
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.
Circulation 2007;116(17):1942-51.
2007: Romana Femia; Michaela Kozakova; Monica Nannipieri; Clicerio Gonzales-Villalpando; Michael P Stern; Steven M Haffner; Ele Ferrannini
Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(10):2244-9.
2007: William H Herman; Yong Ma; Gabriel Uwaifo; Steven M Haffner; Steven E Kahn; Edward S Horton; John M Lachin; Maria G Montez; Tina Brenneman; Elizabeth Barrett-Connor
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program.
Diabetes care 2007;30(10):2453-7.
2007: Steven M Haffner
Abdominal adiposity and cardiometabolic risk: do we have all the answers?
The American journal of medicine 2007;120(9 Suppl 1):S10-6; discussion S16-7.
2007: Carlos Lorenzo; Manuel Serrano-Ríos; María T Martínez Larrad; Clicerio González-Villalpando; José L González-Sánchez; María J Martínez-Calatrava; Rafael Gabriel; Steven M Haffner
Is waist circumference an essential component of the metabolic syndrome?
Diabetes care 2007;30(8):2141-2.
2007: Jobien K Olijhoek; Yolanda van der Graaf; Steven M Haffner; Frank L J Visseren
Defining the metabolic syndrome: Resolving unresolved issues?
European journal of internal medicine 2007;18(4):309-13.
2007: Anthony J G Hanley; Lynne E Wagenknecht; Andreas Festa; Ralph B D'Agostino; Steven M Haffner
Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
Diabetes care 2007;30(7):1819-27.
2007: Anthony J G Hanley; Donald Bowden; Lynne E Wagenknecht; Aarthi Balasubramanyam; Carl Langfeld; Mohammed F Saad; Jerome I Rotter; Xiuqing Guo; Yii-Der I Chen; Michael Bryer-Ash; Jill M Norris; Steven M Haffner
Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans.
The Journal of clinical endocrinology and metabolism 2007;92(7):2665-71.
2007: Xavier Pi-Sunyer; George Blackburn; frederick brancati; George A Bray; Renee Bright; Jeanne M Clark; Jeffrey M Curtis; Mark A Espeland; John P Foreyt; Kathryn Graves; Steven M Haffner; Barbara Harrison; James O Hill; Edward S Horton; John Jakicic; Robert W Jeffery; Karen C Johnson; Steven Kahn; David E Kelley; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Brenda Montgomery; David M Nathan; Jennifer Patricio; Anne Peters; J Bruce Redmon; Rebecca S Reeves; Donna Ryan; Monika Maria Safford; Brent Van Dorsten; Thomas A Wadden; Lynne Wagenknecht; Jacqueline Wesche-Thobaben; Rena R Wing; Susan Z Yanovski
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.
Diabetes care 2007;30(6):1374-83.
2007: Wilfred Y Fujimoto; Kathleen Jablonski; George A Bray; Andrea Kriska; Elizabeth Barrett-Connor; Steven M Haffner; Robert Hanson; James O Hill; Van Hubbard; E Stamm; F Xavier Pi-Sunyer
Body size and shape changes and the risk of diabetes in the diabetes prevention program.
Diabetes 2007;56(6):1680-5.
2007: Carlos Lorenzo; Manuel Serrano-Ríos; María T Martínez Larrad; Clicerio Gonzalez-Villalpando; Ken Williams; Rafael Gabriel; Michael P Stern; Steven M Haffner
Which obesity index best explains prevalence differences in type 2 diabetes mellitus?
Obesity (Silver Spring, Md.) 2007;15(5):1294-301.
2007: Rebecca L Sedjo; Tim E Byers; Theodore R Levin; Steven M Haffner; Mohammed F Saad; Janet A Tooze; Ralph B D'Agostino
Change in body size and the risk of colorectal adenomas.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):526-31.
2007: Theodore Mazzone; Peter M Meyer; George T Kondos; Michael H Davidson; Steven B Feinstein; Ralph B D'Agostino; Alfonso Perez; Steven M Haffner
Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes.
Diabetes 2007;56(3):849-55.
2007: Steven M Haffner
Unmet needs in controlling metabolic disease.
Reviews in cardiovascular medicine 2007;8 Suppl 4():S17-24.
2007: Carlos Lorenzo; Ken Williams; Kelly J Hunt; Steven M Haffner
The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
Diabetes care 2007;30(1):8-13.
2007: Mark O Goodarzi; Kent D Taylor; Xiuqing Guo; John E Hokanson; Steven M Haffner; Jinrui Cui; Yii-Der I Chen; Lynne E Wagenknecht; Richard N Bergman; Jerome I Rotter
Haplotypes in the lipoprotein lipase gene influence fasting insulin and discovery of a new risk haplotype.
The Journal of clinical endocrinology and metabolism 2007;92(1):293-6.
2006: Steven E Kahn; Steven M Haffner; Mark A Heise; William H Herman; Rury R Holman; Nigel P Jones; Barbara G Kravitz; John M Lachin; Mary O'Neill; Bernard Zinman; Giancarlo Viberti
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
The New England journal of medicine 2006;355(23):2427-43.
2006: Theodore Mazzone; Peter M Meyer; Steven B Feinstein; Michael H Davidson; George T Kondos; Ralph B D'Agostino; Alfonso Perez; Jean-Claude PROVOST; Steven M Haffner
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.
JAMA : the journal of the American Medical Association 2006;296(21):2572-81.
2006: George Bray; Edward Gregg; Steven M Haffner; Xavier F Pi-Sunyer; Lynne E WagenKnecht; Michael Walkup; Rena Wing
Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2006;3(3):202-15.
2006: Giancarlo Viberti; John M Lachin; R Holman; Bernard Zinman; Steven M Haffner; Barbara G Kravitz; Mark A Heise; Nigel P Jones; Mary O'Neill; Freed Martin; Steven E Kahn; William H Herman
A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(12):1289-94.
2006: Ramon Lloret; Joseph Ycas; Michael Stein; Steven M Haffner
Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial).
The American journal of cardiology 2006;98(6):768-73.
2006: Prakash Deedwania; Philip J Barter; Rafael Carmena; Jean-Charles Fruchart; Scott M Grundy; Steven M Haffner; John J P Kastelein; John C LaRosa; Holly Schachner; James Shepherd; David D Waters
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
Lancet 2006;368(9539):919-28.
2006: Beth S Sutton; Carl D Langefeld; Joel K Campbell; Steven M Haffner; Jill M Norris; Ann L Scherzinger; Lynne E Wagenknecht; Donald W Bowden
Genetic mapping of a 17q chromosomal region linked to obesity phenotypes in the IRAS family study.
International journal of obesity (2005) 2006;30(9):1433-41.
2006: Steven E Kahn; Bernard Zinman; Steven M Haffner; Mary O'Neill; Barbara G Kravitz; Dahong Yu; Freed Martin; William H Herman; Rury R Holman; Nigel P Jones; John M Lachin; Giancarlo Viberti
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
Diabetes 2006;55(8):2357-64.
2006: Jacques Baillargeon; Elizabeth A Platz; David P Rose; Bradley Pollock; Donna Pauler Ankerst; Steven M Haffner; Betsy Higgins; Anna Lokshin; Dean A Troyer; Javier Hernandez; Steve Lynch; Robin J Leach; Ian M Thompson
Obesity, adipokines, and prostate cancer in a prospective population-based study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(7):1331-5.
2006: Holly B Cassells; Steven M Haffner
The metabolic syndrome: risk factors and management.
The Journal of cardiovascular nursing 2006;21(4):306-13.
2006: Thomas P Bersot; Steven M Haffner; William S Harris; Kenneth A Kellick; Charlene M Morris
Hypertriglyceridemia: management of atherogenic dyslipidemia.
The Journal of family practice 2006;55(7):S1-8.
2006: Steven M Haffner
Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
Obesity (Silver Spring, Md.) 2006;14 Suppl 3():121S-127S.
2006: James Shepherd; Philip J Barter; Rafael Carmena; Prakash Deedwania; Jean-Charles Fruchart; Steven M Haffner; Judith Hsia; Andrei Breazna; John C LaRosa; Scott Grundy; David Waters
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.
Diabetes care 2006;29(6):1220-6.
2006: Andrea M Kriska; Sharon L Edelstein; Richard Hamman; Amy Otto; George A Bray; Elizabeth J Mayer-Davis; Rena R Wing; Edward S Horton; Steven M Haffner; Judith G Regensteiner
Physical activity in individuals at risk for diabetes: Diabetes Prevention Program.
Medicine and science in sports and exercise 2006;38(5):826-32.
2006: Steven M Haffner
Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns.
The American journal of medicine 2006;119(5 Suppl 1):S3-9.
2006: Deepak L Bhatt; Keith A A Fox; Werner Hacke; Peter B Berger; Henry R Black; William E Boden; Patrice Cacoub; Eric A Cohen; Mark A Creager; J Donald Easton; Marcus Flather; Steven M Haffner; Christian W Hamm; Graeme J Hankey; S Claiborne Johnston; Koon-Hou Mak; Jean-Louis Mas; Gilles Montalescot; Thomas A Pearson; Philippe Gabriel STEG; Steven R Steinhubl; Michael A Weber; Danielle M Brennan; Liz Fabry-Ribaudo; Joan Booth; Eric J Topol
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
The New England journal of medicine 2006;354(16):1706-17.
2006: Andreas Festa; Ken Williams; Russell P Tracy; Lynne E Wagenknecht; Steven M Haffner
Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
Circulation 2006;113(14):1753-9.
2006: Andreas Festa; Ken Williams; Ralph D'Agostino; Lynne E Wagenknecht; Steven M Haffner
The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.
Diabetes 2006;55(4):1114-20.
2006: Steven M Haffner
Diabetes and the metabolic syndrome--when is it best to intervene to prevent?
Atherosclerosis. Supplements 2006;7(1):3-10.
2006: Steven M Haffner; Luis M Ruilope; Björn Dahlöf; Eric Abadie; Stuart Kupfer; Faiez Zannad
Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials.
Journal of cardiovascular pharmacology 2006;47(3):469-75.
2006: Carlos Lorenzo; Manuel Serrano-Ríos; María T Martínez Larrad; José L González-Sánchez; Segundo Seclén; Arturo Villena; Clicerio Gonzalez-Villalpando; Ken Williams; Steven M Haffner
Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects.
Diabetes care 2006;29(3):685-91.
2006: Carlos Lorenzo; Ken Williams; Kelly J Hunt; Steven M Haffner
Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study.
Diabetes care 2006;29(3):625-30.
2006: Philip J Barter; C M Ballantyne; R Carmena; Manuel Castro Cabezas; M John Chapman; P Couture; J de Graaf; P N Durrington; O Faergeman; J Frohlich; Curt D Furberg; C Gagne; Steven M Haffner; S E Humphries; Ingmar Jungner; R M Krauss; Peter O Kwiterovich; S Marcovina; C J Packard; Thomas A Pearson; K Srinath Reddy; Robert S Rosenson; Nizal Sarrafzadegan; Allan D Sniderman; A F Stalenhoef; E Stein; P J Talmud; A M Tonkin; Göran Walldius; K M S Williams
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
Journal of internal medicine 2006;259(3):247-58.
2006: Steven M Haffner
The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.
The American journal of cardiology 2006;97(2A):3A-11A.
2006: Manel Pladevall; Bonita Singal; L Keoki Williams; Carlos Brotons; Heidi Guyer; Josep Sadurni; Carles Falces; Manuel Serrano-Rios; Rafael Gabriel; Jonathan E Shaw; Paul Z Zimmet; Steven M Haffner
A single factor underlies the metabolic syndrome: a confirmatory factor analysis.
Diabetes care 2006;29(1):113-22.
2005: Anthony J G Hanley; Andrew J Karter; Ken Williams; Andreas Festa; Ralph B D'Agostino; Lynne E Wagenknecht; Steven M Haffner
Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
Circulation 2005;112(24):3713-21.
2005: Anthony J G Hanley; Ken Williams; Andreas Festa; Lynne E Wagenknecht; Ralph B D'Agostino; Steven M Haffner
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.
Diabetes 2005;54(11):3140-7.
2005: Carlos Lorenzo; Ken Williams; Clicerio Gonzalez-Villalpando; Steven M Haffner
The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity.
Diabetes care 2005;28(10):2480-5.
2005: Beth S Sutton; Carl D Langefeld; Adrienne H Williams; Jill M Norris; Mohammed F Saad; Steven M Haffner; Donald W Bowden
Association of proopiomelanocortin gene polymorphisms with obesity in the IRAS family study.
Obesity research 2005;13(9):1491-8.
2005: Deepak L Bhatt; Keith A A Fox; Werner Hacke; Peter B Berger; Henry R Black; William E Boden; Patrice Cacoub; Eric A Cohen; Mark A Creager; J Donald Easton; Marcus Flather; Steven M Haffner; Christian W Hamm; Graeme J Hankey; S Claiborne Johnston; Koon-Hou Mak; Jean-Louis Mas; Gilles Montalescot; Thomas A Pearson; Philippe Gabriel STEG; Steven R Steinhubl; Michael A Weber; Joan Booth; Eric J Topol
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
American heart journal 2005;150(3):401.
2005: Steven M Haffner
Rationale for new American Diabetes Association Guidelines: are national cholesterol education program goals adequate for the patient with diabetes mellitus?
The American journal of cardiology 2005;96(4A):33E-36E.
2005: Ilkka Vauhkonen; Leo Niskanen; Mikael Knip; Leena Moilanen Mykkänen; Steven M Haffner; Matti Uusitupa; Markku Laakso
Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(2):265-73.
2005: Abbas E Kitabchi; Marinella Temprosa; William C Knowler; Steven E Kahn; Sarah E Fowler; Steven M Haffner; Reubin Andres; Christopher D Saudek; Sharon L Edelstein; Richard Arakaki; Mary Beth Murphy; Harry Shamoon
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
Diabetes 2005;54(8):2404-14.
2005: Aida Jimenez Corona; David Rivera Martinez; Mauricio Hernandez Avila; Steven M Haffner; Ken Williams; Maria Elena González Villalpando; Jesus Simon; Michael P Stern; Clicerio Gonzalez-Villalpando
Microalbuminuria as a predictor of myocardial infarction in a Mexican population: the Mexico City Diabetes Study.
Kidney international. Supplement 2005;(97):S34-9.
2005: Monica Nannipieri; Clicerio Gonzales; Simona Baldi; Rosalinda Posadas-Sánchez; Ken Williams; Steven M Haffner; Michael P Stern; Ele Ferrannini
Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.
Diabetes care 2005;28(7):1757-62.
2005: Beth S Sutton; Stefanie Weinert; Carl D Langefeld; Adrienne H Williams; Joel K Campbell; Mohammed F Saad; Steven M Haffner; Jill M Norris; Donald W Bowden
Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study.
Human genetics 2005;117(2-3):107-18.
2005: Peter Libby; David M Nathan; KM Abraham; John D Brunzell; Judith E Fradkin; Steven M Haffner; Willa Hsueh; Marian Rewers; B Tibor Roberts; Peter J Savage; Sonia Skarlatos; Momtaz Wassef; Cristina Rabadan-Diehl
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus.
Circulation 2005;111(25):3489-93.
2005: Andreas Festa; Ken Williams; Anthony J G Hanley; James D Otvos; David C Goff; Lynne E Wagenknecht; Steven M Haffner
Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
Circulation 2005;111(25):3465-72.
2005: Anthony J G Hanley; James B Meigs; Ken Williams; Steven M Haffner; Ralph B D'Agostino
Re: "(Mis)use of factor analysis in the study of insulin resistance syndrome".
American journal of epidemiology 2005;161(12):1182-4.
2005: Wahida Karmally; Maria G Montez; Walter Palmas; Wendy Martinez; Anita Branstetter; Rajasekhar Ramakrishnan; Steve Holleran; Steven M Haffner; Henry N Ginsberg
Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans.
Journal of the American Dietetic Association 2005;105(6):967-70.
2005: Xiuqing Guo; Jinrui Cui; Lynne E Wagenknecht; Jill M Norris; Steven M Haffner; Christine Darwin; Sujata Jinagouda; Jerome I Rotter; Mohammed F Saad
Cosegregation of albuminuria and blood pressure: the Insulin Resistance Atherosclerosis (IRAS) family study.
American journal of hypertension 2005;18(6):823-7.
2005: Andreas Festa; Steven M Haffner
Inflammation and cardiovascular disease in patients with diabetes: lessons from the Diabetes Control and Complications Trial.
Circulation 2005;111(19):2414-5.
2005: Steven M Haffner; Marinella Temprosa; Jill Crandall; Sarah Fowler; Ronald B Goldberg; Edward S Horton; Santica Marcovina; Kieren Mather; Trevor Orchard; Robert E Ratner; Elizabeth Barrett-Connor
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance.
Diabetes 2005;54(5):1566-72.
2005: A J Karter; R B D'Agostino; Elizabeth J Mayer-Davis; L E Wagenknecht; A J G Hanley; Richard Hamman; R Bergman; M F Saad; Steven M Haffner
Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS).
Diabetes, obesity & metabolism 2005;7(3):230-8.
2005: Trevor J Orchard; Marinella Temprosa; Ronald B Goldberg; Steven M Haffner; Robert E Ratner; Santica Marcovina; Sarah Fowler
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
Annals of internal medicine 2005;142(8):611-9.
2005: Robert E Ratner; Ronald B Goldberg; Steven M Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
Diabetes care 2005;28(4):888-94.
2005: Carlos Lorenzo; Ken Williams; Clicerio Gonzalez-Villalpando; Michael P Stern; Helen Hazuda; Steven M Haffner
Lower hypertension risk in Mexico City than in San Antonio.
American journal of hypertension 2005;18(3):385-91.
2005: George Davey Smith; Yiscah Bracha; Kenneth H Svendsen; James D Neaton; Steven M Haffner; Lewis H Kuller
Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.
Annals of internal medicine 2005;142(5):313-22.
2005: David C Goff; Ralph B D'Agostino; Steven M Haffner; James D Otvos
Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
Metabolism: clinical and experimental 2005;54(2):264-70.
2005: Andrew J Drexler; Richard W Nesto; Martin J Abrahamson; George L Bakris; David Bell; John Brunzell; Paresh Dandona; Jaime Davidson; Vivian Fonseca; Michael Fowler; Robert Frye; Thomas Giles; Steven M Haffner; Norman Hollenberg; Willa Hsueh; Ronald Law; Jorge Plutzky; Robert Ratner; Jane Reusch; Andrew Selwyn; James R Sowers; Kathleen L Wyne; Lawrence H Young
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.
Metabolic syndrome and related disorders 2005;3(2):147-73.
2005: Stephen S Rich; Donald W Bowden; Steven M Haffner; Jill M Norris; Mohammed F Saad; Braxton D Mitchell; Jerome I Rotter; Carl D Langefeld; Catherine C Hedrick; Lynne E Wagenknecht; Richard N Bergman
A genome scan for fasting insulin and fasting glucose identifies a quantitative trait locus on chromosome 17p: the insulin resistance atherosclerosis study (IRAS) family study.
Diabetes 2005;54(1):290-5.
2005: Jill M Norris; Carl D Langefeld; Ann L Scherzinger; Stephen S Rich; E Bookman; Stephanie R Beck; Mohammed F Saad; Steven M Haffner; R N Bergman; Donald W Bowden; Lynne E Wagenknecht
Quantitative trait loci for abdominal fat and BMI in Hispanic-Americans and African-Americans: the IRAS Family study.
International journal of obesity (2005) 2005;29(1):67-77.
2004: Bernard Zinman; Steven E Kahn; Steven M Haffner; Mary O'Neill; Mark A Heise; Freed Martin
Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe.
Diabetes 2004;53(12):3193-200.
2004: Michael P Stern; Ken Williams; Clicerio González-Villalpando; Kelly J Hunt; Steven M Haffner
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
Diabetes care 2004;27(11):2676-81.
2004: Naveed Sattar; Ken Williams; Allan D Sniderman; Ralph D'Agostino; Steven M Haffner
Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.
Circulation 2004;110(17):2687-93.
2004: Anthony J G Hanley; Ken Williams; Andreas Festa; Lynne E Wagenknecht; Ralph B D'Agostino; Judy Kempf; Bernard Zinman; Steven M Haffner
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
Diabetes 2004;53(10):2623-32.
2004: Kelly J Hunt; Roy G Resendez; Ken Williams; Steven M Haffner; Michael P Stern
National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
Circulation 2004;110(10):1251-7.
2004: Steven M Haffner
Type 2 diabetes and the metabolic syndrome: National Cholesterol Education Program guidelines and supporting evidence.
Critical pathways in cardiology 2004;3(3 Suppl):S12-4.
2004: Ralph B D'Agostino; Richard Hamman; Andrew J Karter; Leena Mykkanen; Lynne E Wagenknecht; Steven M Haffner
Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Diabetes care 2004;27(9):2234-40.
2004: Stephen S Rich; Donald W Bowden; Steven M Haffner; Jill M Norris; Mohammed F Saad; Braxton D Mitchell; Jerome I Rotter; Carl D Langefeld; Lynne E Wagenknecht; Richard N Bergman
Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.
Diabetes 2004;53(7):1866-75.
2004: Anthony J G Hanley; Andreas Festa; Ralph B D'Agostino; Lynne E Wagenknecht; Peter J Savage; Russell P Tracy; Mohammed F Saad; Steven M Haffner
Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.
Diabetes 2004;53(7):1773-81.
2004: James B Meigs; Ken Williams; Lisa M Sullivan; Kelly J Hunt; Steven M Haffner; Michael P Stern; Clicerio González-Villalpando; Jessica S Perhanidis; David M Nathan; Ralph B D'Agostino; Ralph B D'Agostino; Peter W F Wilson
Using metabolic syndrome traits for efficient detection of impaired glucose tolerance.
Diabetes care 2004;27(6):1417-26.
2004: Andreas Festa; Ralph D'Agostino; Anthony J G Hanley; Andrew J Karter; Mohammed F Saad; Steven M Haffner
Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
Diabetes 2004;53(6):1549-55.
2004: Mohammed F Saad; Marian Rewers; Joseph Selby; George Howard; Sujata Jinagouda; Salwa Fahmi; Daniel J Zaccaro; Richard N Bergman; Peter J Savage; Steven M Haffner
Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study.
Hypertension 2004;43(6):1324-31.
2004: Braxton D Mitchell; Daniel J Zaccaro; Lynne E Wagenknecht; Ann L Scherzinger; Richard N Bergman; Steven M Haffner; John Hokanson; Jill M Norris; Jerome I Rotter; Mohammed F Saad
Insulin sensitivity, body fat distribution, and family diabetes history: the IRAS Family Study.
Obesity research 2004;12(5):831-9.
2004: John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard Hamman
The prevalence of diabetic retinopathy among adults in the United States.
Archives of ophthalmology 2004;122(4):552-63.
2004: Marian Rewers; Daniel J Zaccaro; Ralph D'Agostino; Steven M Haffner; Mohammed F Saad; Joe V Selby; Richard Bergman; Peter Savage
Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study.
Diabetes care 2004;27(3):781-7.
2004: W E Feeman; Naveed Sattar; Denis St J OReilly; Chris J Packard; James Shepherd; Allan Gaw; Peter W Macfarlane; Stuart M Cobbe; Olga Scherbakova; Ian Ford; Steven M Haffner; Chris Isles
Metabolic syndrome and diabetes mellitus.
Circulation 2004;109(3):E23.
2004: Jeannette T Bensen; Fang-Chi Hsu; W Mark Brown; Beth S Sutton; Jill M Norris; Russell P Tracy; Nancy S Jenny; Mohammed F Saad; Steven M Haffner; Donald W Bowden; Carl D Langefeld
Association analysis of the plasminogen activator inhibitor-1 4G/5G polymorphism in Hispanics and African Americans: the IRAS family study.
Human heredity 2004;57(3):128-37.
2004: Steven M Haffner
Dyslipidemia management in adults with diabetes.
Diabetes care 2004;27 Suppl 1():S68-71.
2003: Steven M Haffner; Holly Cassells
Hyperglycemia as a cardiovascular risk factor.
The American journal of medicine 2003;115 Suppl 8A():6S-11S.
2003: Carlos Lorenzo; Manuel Serrano-Ríos; María T Martínez Larrad; Rafael Gabriel; Ken Williams; Juan A Gomez Gerique; Michael P Stern; Steven M Haffner
Central adiposity determines prevalence differences of the metabolic syndrome.
Obesity research 2003;11(12):1480-7.
2003: Chamukuttan Snehalatha; Bheekamchand Mukesh; Mary Simon; Vijay Viswanathan; Steven M Haffner; Ambady Ramachandran
Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians.
Diabetes care 2003;26(12):3226-9.
2003: Kelly J Hunt; Roy G Resendez; Ken Williams; Steven M Haffner; Michael P Stern; Helen Hazuda
All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox".
American journal of epidemiology 2003;158(11):1048-57.
2003: Ken Williams; Allan D Sniderman; Naveed Sattar; Ralph D'Agostino; Lynne E Wagenknecht; Steven M Haffner
Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).
Circulation 2003;108(19):2312-6.
2003: Mark A Espeland; Gregory Evans; Lynne E Wagenknecht; Daniel H O'Leary; Daniel J Zaccaro; John R Crouse; George Howard; Steven M Haffner
Site-specific progression of carotid artery intimal-medial thickness.
Atherosclerosis 2003;171(1):137-43.
2003: Steven M Haffner; H B Cassells
Metabolic syndrome - a new risk factor of coronary heart disease?
Diabetes, obesity & metabolism 2003;5(6):359-70.
2003: Anthony J G Hanley; Lynne E Wagenknecht; Ralph B D'Agostino; Bernard Zinman; Steven M Haffner
Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome.
Diabetes 2003;52(11):2740-7.
2003: Carlos Lorenzo; Mayor Okoloise; Ken Williams; Michael P Stern; Steven M Haffner
The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
Diabetes care 2003;26(11):3153-9.
2003: Andreas Festa; Anthony J G Hanley; Russell P Tracy; Ralph D'Agostino; Steven M Haffner
Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
Circulation 2003;108(15):1822-30.
2003: Lynne E Wagenknecht; Carl D Langefeld; Ann L Scherzinger; Jill M Norris; Steven M Haffner; Mohammed F Saad; Richard N Bergman
Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.
Diabetes 2003;52(10):2490-6.
2003: Steven M Haffner; Ralph D'Agostino; Andreas Festa; Richard N Bergman; Leena Mykkänen; Andrew J Karter; Mohammed F Saad; Lynne E Wagenknecht
Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
Diabetes care 2003;26(10):2796-803.
2003: Donna Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.
Controlled clinical trials 2003;24(5):610-28.
2003: Kelly J Hunt; Ken Williams; David Rivera; Daniel H O'Leary; Steven M Haffner; Michael P Stern; Clicerio González-Villalpando
Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(10):1845-50.
2003: Steven M Haffner; Heinrich Taegtmeyer
Epidemic obesity and the metabolic syndrome.
Circulation 2003;108(13):1541-5.
2003: Michael J Domanski; Heidi Krause-Steinrauf; Prakash Deedwania; dean follmann; Jalal K Ghali; Edward Gilbert; Steven M Haffner; Richard Katz; JoAnn Lindenfeld; Brian D Lowes; Wade Martin; Frank A McGrew; Michael R Bristow
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.
Journal of the American College of Cardiology 2003;42(5):914-22.
2003: Steven M Haffner
Managing dyslipidemia in adults with diabetes.
Managed care (Langhorne, Pa.) 2003;12(9 Suppl):10-5.
2003: Steven M Haffner
Insulin resistance, inflammation, and the prediabetic state.
The American journal of cardiology 2003;92(4A):18J-26J.
2003: Koon-Hou Mak; Steven M Haffner
Diabetes abolishes the gender gap in coronary heart disease.
European heart journal 2003;24(15):1385-6.
2003: Richard N Bergman; Daniel J Zaccaro; Richard Watanabe; Steven M Haffner; Mohammed F Saad; Jill M Norris; Lynne E Wagenknecht; James E Hokanson; Jerome I Rotter; Steven S Rich
Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin.
Diabetes 2003;52(8):2168-74.
2003: James B Meigs; Peter W F Wilson; David M Nathan; Ralph B D'Agostino; Ken Williams; Steven M Haffner
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.
Diabetes 2003;52(8):2160-7.
2003: Manel Pladevall; L Keoki Williams; Heidi Guyer; Josep Sadurní; Carles Falces; Anna Ribes; Carles Paré; Carlos Brotons; Rafael Gabriel; Manuel Serrano-Ríos; Steven M Haffner
The association between leptin and left ventricular hypertrophy: a population-based cross-sectional study.
Journal of hypertension 2003;21(8):1467-73.
2003: Naveed Sattar; Allan Gaw; Olga Scherbakova; Ian Ford; Denis St J O'Reilly; Steven M Haffner; Chris Isles; Peter W Macfarlane; Chris J Packard; Stuart M Cobbe; James Shepherd
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
Circulation 2003;108(4):414-9.
2003: Clicerio González-Villalpando; David Rivera-Martínez; Martín Cisneros-Castólo; Ma Elena González-Villalpando; Jesús Simón; Ken Williams; Steven M Haffner; Michael P Stern
Seven-year incidence and progression of obesity. Characterization of body fat pattern evolution in low-income Mexico City urban population.
Archives of medical research 2003;34(4):348-53.
2003: Steven M Haffner
Pre-diabetes, insulin resistance, inflammation and CVD risk.
Diabetes research and clinical practice 2003;61 Suppl 1():S9-S18.
2003: Steven M Haffner
Statin therapy for the treatment of diabetic dyslipidemia.
Diabetes/metabolism research and reviews 2003;19(4):280-7.
2003: James P Burke; Ken Williams; K Narayan; Cynthia L Leibson; Steven M Haffner; Michael P Stern
A population perspective on diabetes prevention: whom should we target for preventing weight gain?
Diabetes care 2003;26(7):1999-2004.
2003: Lynne E Wagenknecht; Daniel J Zaccaro; Mark A Espeland; Andrew J Karter; Daniel H O'Leary; Steven M Haffner
Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(6):1035-41.
2003: Andreas Festa; Ralph D'Agostino; Steven S Rich; Nancy S Jenny; Russell P Tracy; Steven M Haffner
Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
Circulation 2003;107(19):2422-7.
2003: Charles M Alexander; Pamela B Landsman; Steven M Teutsch; Steven M Haffner
NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.
Diabetes 2003;52(5):1210-4.
2003: Leora Henkin; Richard N Bergman; Donald W Bowden; Darrell L Ellsworth; Steven M Haffner; Carl D Langefeld; Braxton D Mitchell; Jill M Norris; Marian Rewers; Mohammed F Saad; Elizabeth Stamm; Lynne E Wagenknecht; Stephen S Rich
Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods.
Annals of epidemiology 2003;13(4):211-7.
2003: Michael P Stern; Ken Williams; Steven M Haffner
Do we need the oral glucose tolerance test to identify future cases of type 2 diabetes?
Diabetes care 2003;26(3):940-1.
2003: David C Goff; Daniel J Zaccaro; Steven M Haffner; Mohammed F Saad
Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study.
Diabetes care 2003;26(3):805-9.
2003: Anthony J G Hanley; Ken Williams; Clicerio Gonzalez; Ralph B D'Agostino; Lynne E Wagenknecht; Michael P Stern; Steven M Haffner
Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study.
Diabetes 2003;52(2):463-9.
2003: John E Hokanson; Carl D Langefeld; Braxton D Mitchell; Leslie A Lange; David C Goff; Steven M Haffner; Mohammed F Saad; Jerome I Rotter
Pleiotropy and heterogeneity in the expression of atherogenic lipoproteins: the IRAS Family Study.
Human heredity 2003;55(1):46-50.
2003: Steven M Haffner
Management of dyslipidemia in adults with diabetes.
Diabetes care 2003;26 Suppl 1():S83-6.
2002: James R Sowers; Steven M Haffner
Treatment of cardiovascular and renal risk factors in the diabetic hypertensive.
Hypertension 2002;40(6):781-8.
2002: Jorge Plutzky; Giancarlo Viberti; Steven M Haffner
Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets.
Journal of diabetes and its complications 2002;16(6):401-15.
2002: Andreas Festa; R D'Agostino; R P Tracy; Steven M Haffner
C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(11):939-43.
2002: Thang S Han; Naveed Sattar; Ken Williams; Clicerio Gonzalez-Villalpando; Michael E J Lean; Steven M Haffner
Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.
Diabetes care 2002;25(11):2016-21.
2002: Steven M Haffner
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
The American journal of cardiology 2002;90(8A):55i-61i.
2002: Steven M Haffner
Metabolic syndrome, diabetes and coronary heart disease.
International journal of clinical practice. Supplement 2002;(132):31-7.
2002: Nicola Abate; Steven M Haffner; Abhimanyu Garg; ronald peshock; Scott M Grundy
Sex steroid hormones, upper body obesity, and insulin resistance.
The Journal of clinical endocrinology and metabolism 2002;87(10):4522-7.
2002: Michael P Stern; Pedram Fatehi; Ken Williams; Steven M Haffner
Predicting future cardiovascular disease: do we need the oral glucose tolerance test?
Diabetes care 2002;25(10):1851-6.
2002: Giancarlo Viberti; Steven E Kahn; Douglas A Greene; William H Herman; Bernard Zinman; Rury R Holman; Steven M Haffner; Daniel Levy; John M Lachin; Rhona A Berry; Mark A Heise; Nigel P Jones; Freed Martin
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
Diabetes care 2002;25(10):1737-43.
2002: KO Haustein; Steven M Haffner; B G Woodcock
A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients.
International journal of clinical pharmacology and therapeutics 2002;40(9):404-18.
2002: Sabine Fischer; Markolf Hanefeld; Steven M Haffner; C Fusch; Uta Schwanebeck; Carsta Köhler; K Fücker; Ulrich Julius
Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass.
Acta diabetologica 2002;39(3):105-10.
2002: Thang S Han; Ken Williams; Naveed Sattar; Kelly J Hunt; Michael E J Lean; Steven M Haffner
Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
Obesity research 2002;10(9):923-31.
2002: Kelly J Hunt; Ken Williams; Roy G Resendez; Helen Hazuda; Steven M Haffner; Michael P Stern
All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox".
Diabetes care 2002;25(9):1557-63.
2002: Steven M Haffner; Andrew S Greenberg; Wayde M Weston; Hongzi Chen; Ken Williams; Freed Martin
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Circulation 2002;106(6):679-84.
2002: Anthony J G Hanley; Andrew J Karter; Andreas Festa; Ralph D'Agostino; Lynne E Wagenknecht; Peter Savage; Russell P Tracy; Mohammed F Saad; Steven M Haffner
Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study.
Diabetes 2002;51(8):2642-7.
2002: Steven M Haffner
Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials.
International journal of clinical practice. Supplement 2002;(129):33-9.
2002: Steven M Haffner; Ronald B Goldberg
New strategies for the treatment of diabetic dyslipidemia.
Diabetes care 2002;25(7):1237-9.
2002: Anthony J G Hanley; Ken Williams; Michael P Stern; Steven M Haffner
Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.
Diabetes care 2002;25(7):1177-84.
2002: Frank B Hu; Meir J Stampfer; Steven M Haffner; Caren G Solomon; Walter C Willett; JoAnn E Manson
Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes.
Diabetes care 2002;25(7):1129-34.
2002: Steven M Haffner
Glucose-tolerance testing in acute myocardial infarction.
Lancet 2002;359(9324):2127-8.
2002: Steven M Haffner; Anthony J G Hanley
Do increased proinsulin concentrations explain the excess risk of coronary heart disease in diabetic and prediabetic subjects?
Circulation 2002;105(17):2008-9.
2002: Michael P Stern; Ken Williams; Steven M Haffner
Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?
Annals of internal medicine 2002;136(8):575-81.
2002: Anthony J G Hanley; Ralph D'Agostino; Lynne E Wagenknecht; Mohammed F Saad; Peter J Savage; Richard Bergman; Steven M Haffner
Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.
Diabetes 2002;51(4):1263-70.
2002: Andreas Festa; Ralph D'Agostino; Russell P Tracy; Steven M Haffner
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Diabetes 2002;51(4):1131-7.
2002: Markolf Hanefeld; Steven M Haffner; Mario Menschikowski; Carsta Koehler; Theodora Temelkova-Kurktschiev; Jan Wildbrett; Sabine Fischer
Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes.
Diabetes research and clinical practice 2002;55(3):221-7.
2002: Carlos Lorenzo; Manuel Serrano-Rios; Maria T Martinez-Larrad; Rafael Gabriel; Ken Williams; Clicerio Gonzalez-Villalpando; Michael P Stern; Helen Hazuda; Steven M Haffner
Prevalence of hypertension in Hispanic and non-Hispanic white populations.
Hypertension 2002;39(2):203-8.
2002: Steven M Haffner
Cholesterol goals established for patients with diabetes and metabolic syndrome.
The American journal of managed care 2002;Suppl():6-7.
2001: Carlos Lorenzo; Manuel Serrano-Rios; Maria T Martinez-Larrad; Rafael Gabriel; Ken Williams; Clicerio Gonzalez-Villalpando; Michael P Stern; Helen Hazuda; Steven M Haffner
Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study.
Diabetes care 2001;24(12):2059-64.
2001: A Festa; R D'Agostino; K Williams; A J Karter; Elizabeth J Mayer-Davis; R P Tracy; Steven M Haffner
The relation of body fat mass and distribution to markers of chronic inflammation.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2001;25(10):1407-15.
2001: James B Meigs; Steven M Haffner; David M Nathan; Ralph B D'Agostino; Peter W F Wilson
Sample exchange to compare insulin measurements between the San Antonio Heart Study and the Framingham Offspring Study.
Journal of clinical epidemiology 2001;54(10):1031-6.
2001: Steven M Haffner
The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point.
International journal of clinical practice. Supplement 2001;(123):24-6.
2001: James P Burke; K Williams; Steven M Haffner; C G Villalpando; Michael P Stern
Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico.
Diabetes care 2001;24(9):1573-8.
2001: Steven M Haffner
Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors.
Circulation 2001;103(3):346-7.
2000: Andreas Festa; R D'Agostino; P Rautaharju; Leena Mykkänen; Steven M Haffner
Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects.
The American journal of cardiology 2000;86(10):1117-22.
2000: Ronny A Bell; Elizabeth J Mayer-Davis; M A Martin; Ralph B D'Agostino; Steven M Haffner
Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.
Diabetes care 2000;23(11):1630-6.
2000: Andreas Festa; R D'Agostino; George Howard; Leena Mykkänen; R P Tracy; Steven M Haffner
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.
Kidney international 2000;58(4):1703-10.
2000: Ilkka Vauhkonen; Leo Niskanen; Leena Mykkänen; Steven M Haffner; M I J Uusitupa; Markku Laakso
Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes.
European journal of endocrinology / European Federation of Endocrine Societies 2000;143(2):251-60.
2000: Andreas Festa; Ralph D'Agostino; George Howard; Leena Mykkänen; Russell P Tracy; Steven M Haffner
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).
Circulation 2000;102(1):42-7.
2000: Steven M Haffner
Secondary prevention of coronary heart disease: the role of fibric acids.
Circulation 2000;102(1):2-4.
2000: David C Goff; Ralph B D'Agostino; Steven M Haffner; Mohammed F Saad; Lynne E Wagenknecht
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study.
Diabetes care 2000;23(7):1006-11.
2000: Steven M Haffner; R D Agostino; Mohammed F Saad; Daniel H O'Leary; Peter J Savage; Marian Rewers; Joseph Selby; Richard N Bergman; Leena Mykkänen
Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study).
The American journal of cardiology 2000;85(12):1395-400.
2000: Steven M Haffner
Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24 Suppl 2():S56-8.
2000: Christie M Ballantyne; S M Grundy; Albert Oberman; Robert A Kreisberg; Richard J Havel; Philip H Frost; Steven M Haffner
Hyperlipidemia: diagnostic and therapeutic perspectives.
The Journal of clinical endocrinology and metabolism 2000;85(6):2089-112.
2000: Andreas Festa; Ralph D'Agostino; CN Hales; Leena Mykkänen; Steven M Haffner
Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.
Diabetes care 2000;23(5):624-8.
2000: Steven M Haffner
Coronary heart disease in patients with diabetes.
The New England journal of medicine 2000;342(14):1040-2.
2000: Steven M Haffner; Leena Mykkänen; Andreas Festa; J P Burke; Michael P Stern
Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.
Circulation 2000;101(9):975-80.
2000: Steven M Haffner; T Ashraf
Predicting risk reduction of coronary disease in patients who are glucose intolerant: a comparison of treatment with fenofibrate and other lipid-modifying agents.
Managed care interface 2000;13(3):52-8.
2000: Steven M Haffner
Obesity and the metabolic syndrome: the San Antonio Heart Study.
The British journal of nutrition 2000;83 Suppl 1():S67-70.
2000: Steven M Haffner
Clinical relevance of the oxidative stress concept.
Metabolism: clinical and experimental 2000;49(2 Suppl 1):30-4.
2000: Steven M Haffner
Oxidative stress: introduction.
Metabolism: clinical and experimental 2000;49(2 Suppl 1):1-2.
1999: Steven M Haffner; Charles M Alexander; Thomas J Cook; Steve J Boccuzzi; Thomas A Musliner; Terje R Pedersen; John Kjekshus; Kalevi Pyörälä
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
Archives of internal medicine 1999;159(22):2661-7.
1999: Johan Eriksson; Timo T Valle; Jaana Lindström; Steven M Haffner; Anne Louheranta; Matti Uusitupa; Jaakko Tuomilehto
Leptin concentrations and their relation to body fat distribution and weight loss--a prospective study in individuals with impaired glucose tolerance. DPS-study group.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1999;31(11):616-9.
1999: Leena Mykkänen; J Kuusisto; Steven M Haffner; M Laakso; M A Austin
LDL size and risk of coronary heart disease in elderly men and women.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(11):2742-8.
1999: Andreas Festa; Ralph D'Agostino; Leena Mykkänen; Russell P Tracy; CN Hales; B V Howard; Steven M Haffner
LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.
Diabetes care 1999;22(10):1688-93.
1999: Steven M Haffner; Ralph D'Agostino; D Goff; B Howard; Andreas Festa; Mohammed F Saad; Leena Mykkänen
LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(9):2234-40.
1999: Leena Mykkänen; Daniel J Zaccaro; CN Hales; Andreas Festa; Steven M Haffner
The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study.
Diabetologia 1999;42(9):1060-6.
1999: Steven M Haffner
Patients with type 2 diabetes: the case for primary prevention.
The American journal of medicine 1999;107(2A):43S-45S.
1999: Steven M Haffner
Metabolic predictors of hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1999;17(3):S23-8.
1999: Andreas Festa; Nadja Shnawa; Walter Krugluger; Pierre Hopmeier; Guntram Schernthaner; Steven M Haffner
Relative hypoleptinaemia in women with mild gestational diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1999;16(8):656-62.
1999: Andreas Festa; Ralph D'Agostino; P Rautaharju; Daniel H O'Leary; Marian Rewers; Leena Mykkänen; Steven M Haffner
Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS).
Stroke; a journal of cerebral circulation 1999;30(8):1566-71.
1999: James P Burke; Ken Williams; SP Gaskill; Helen Hazuda; Steven M Haffner; Michael P Stern
Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.
Archives of internal medicine 1999;159(13):1450-6.
1999: Steven M Haffner
Epidemiology of insulin resistance and its relation to coronary artery disease.
The American journal of cardiology 1999;84(1A):11J-14J.
1999: L Henkin; Daniel J Zaccaro; Steven M Haffner; Andrew J Karter; Marian Rewers; P Sholinsky; Lynne E Wagenknecht
Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity: the Insulin Resistance Atherosclerosis Study.
Annals of epidemiology 1999;9(5):290-6.
1999: Clicerio González-Villalpando; Michael P Stern; Steven M Haffner; M E González Villapando; S Gaskill; David Rivera-Martínez
Prevalence of hypertension in a Mexican population according to the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure.
Journal of cardiovascular risk 1999;6(3):177-81.
1999: Daniel J Rader; Steven M Haffner
Role of fibrates in the management of hypertriglyceridemia.
The American journal of cardiology 1999;83(9B):30F-35F.
1999: Steven M Haffner
Diabetes, hyperlipidemia, and coronary artery disease.
The American journal of cardiology 1999;83(9B):17F-21F.
1999: C Gonzalez; Michael P Stern; E Gonzalez; D Rivera; J Simon; S Islas; Steven M Haffner
The Mexico City Diabetes Study: a population-based approach to the study of genetic and environmental interactions in the pathogenesis of obesity and diabetes.
Nutrition reviews 1999;57(5 Pt 2):S71-6; discussion S76-7.
1999: Jean W MacCluer; Michael P Stern; Laura A Almasy; L A Atwood; John C Blangero; Anthony G Comuzzie; Bennett Dyke; Steven M Haffner; R D Henkel; James E Hixson; Candace M Kammerer; Michael C Mahaney; Braxton D Mitchell; David L Rainwater; Paul B Samollow; R M Sharp; John VandeBerg; Jeff T Williams
Genetics of atherosclerosis risk factors in Mexican Americans.
Nutrition reviews 1999;57(5 Pt 2):S59-65.
1999: Andreas Festa; Walter Krugluger; Nadja Shnawa; Pierre Hopmeier; Steven M Haffner; Guntram Schernthaner
Trp64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1999;84(5):1695-9.
1999: Steven M Haffner
Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
Diabetes care 1999;22 Suppl 3():C54-6.
1999: Steven M Haffner; Ralph D'Agostino; Leena Mykkänen; Russell Tracy; B Howard; Marian Rewers; Joseph Selby; Peter J Savage; Mohammed F Saad
Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.
Diabetes care 1999;22(4):562-8.
1999: Steven M Haffner; Leena Mykkänen; David L Rainwater; Pauli Karhapää; M Laakso
Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men?
Obesity research 1999;7(2):164-9.
1999: Andreas Festa; Ralph D'Agostino; Leena Mykkänen; Russell Tracy; B V Howard; Steven M Haffner
Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(3):605-10.
1999: Andreas Festa; Ralph D'Agostino; Leena Mykkänen; Russell P Tracy; Daniel J Zaccaro; CN Hales; Steven M Haffner
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
Arteriosclerosis, thrombosis, and vascular biology 1999;19(3):562-8.
1999: David L Rainwater; Braxton D Mitchell; Anthony G Comuzzie; Steven M Haffner
Relationship of low-density lipoprotein particle size and measures of adiposity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1999;23(2):180-9.
1999: Andreas Festa; Nadja Shnawa; Guntram Schernthaner; Steven M Haffner
Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107(7):447-52.
1998: Ilkka Vauhkonen; Leo Niskanen; Steven M Haffner; Sakari Kainulainen; Matti Uusitupa; Markku Laakso
Insulin resistant phenotype is associated with high serum leptin levels in offspring of patients with non-insulin-dependent diabetes mellitus.
European journal of endocrinology / European Federation of Endocrine Societies 1998;139(6):598-604.
1998: Steven M Haffner
Epidemiology of type 2 diabetes: risk factors.
Diabetes care 1998;21 Suppl 3():C3-6.
1998: Lynne E Wagenknecht; Ralph B D'Agostino; Steven M Haffner; Peter J Savage; Marian Rewers
Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study.
Diabetes care 1998;21(11):1812-8.
1998: J T Dubuisson; Lynne E Wagenknecht; Ralph B D'Agostino; Steven M Haffner; Marian Rewers; Mohammed F Saad; A Laws; D M Herrington
Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
Diabetes care 1998;21(11):1790-6.
1998: Steven M Haffner
The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.
Endocrine reviews 1998;19(5):583-92.
1998: Barbara V Howard; Elizabeth J Mayer-Davis; D Goff; Daniel J Zaccaro; A Laws; David C Robbins; Mohammed F Saad; Joseph Selby; Richard Hamman; R M Krauss; Steven M Haffner
Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
Metabolism: clinical and experimental 1998;47(10):1174-9.
1998: Steven M Haffner
Issues in management: the role of insulin in cardiovascular outcomes.
Diabetes/metabolism reviews 1998;14 Suppl 1():S51-6.
1998: Steven M Haffner; H Miettinen; Leena Mykkänen; Michael P Stern
Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/insulin ratio in non-diabetic subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(9):899-905.
1998: Leila J Karhunen; RI Lappalainen; Steven M Haffner; RH Valve; Hely Tuorila; H Miettinen; M I J Uusitupa
Serum leptin, food intake and preferences for sugar and fat in obese women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(8):819-21.
1998: David L Rainwater; Steven M Haffner
Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(8):1335-41.
1998: George Howard; R Bergman; Lynne E Wagenknecht; Steven M Haffner; Peter J Savage; Mohammed F Saad; A Laws; Ralph B D'Agostino
Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
Annals of epidemiology 1998;8(6):358-69.
1998: Steven M Haffner; Ralph D'Agostino; Leena Mykkänen; CN Hales; Peter J Savage; Richard N Bergman; D O'Leary; Marian Rewers; Joseph Selby; Russell Tracy; Mohammed F Saad
Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study.
Stroke; a journal of cerebral circulation 1998;29(8):1498-503.
1998: James P Burke; Steven M Haffner; SP Gaskill; KL Williams; Michael P Stern
Reversion from type 2 diabetes to nondiabetic status. Influence of the 1997 American Diabetes Association criteria.
Diabetes care 1998;21(8):1266-70.
1998: Steven M Haffner; Seppo Lehto; T Rönnemaa; K Pyörälä; M Laakso
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
The New England journal of medicine 1998;339(4):229-34.
1998: Steven M Haffner; Leena Mykkänen; C C Gonzalez; Michael P Stern
Leptin concentrations do not predict weight gain: the Mexico City Diabetes Study.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(7):695-9.
1998: M Wei; S P Gaskill; Steven M Haffner; Michael P Stern
Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
Diabetes care 1998;21(7):1167-72.
1998: Chamukuttan Snehalatha; Ambady Ramachandran; Kumpatla Satyavani; Viswanathan Vijay; Steven M Haffner
Plasma leptin is not associated with insulin resistance and proinsulin in non-diabetic South Asian Indians.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(6):480-4.
1998: Leena Mykkänen; Daniel J Zaccaro; Lynne E Wagenknecht; David C Robbins; M Gabriel; Steven M Haffner
Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study.
Diabetes 1998;47(5):793-800.
1998: Elizabeth J Mayer-Davis; R D'Agostino; Andrew J Karter; Steven M Haffner; Marian Rewers; Mohammed Saad; R N Bergman
Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study.
JAMA : the journal of the American Medical Association 1998;279(9):669-74.
1998: PS Johnston; P U Feig; RF Coniff; A Krol; J A Davidson; Steven M Haffner
Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients.
Diabetes care 1998;21(3):409-15.
1998: Chamukuttan Snehalatha; Ambady Ramachandran; Kumpatla Satyavani; Viswanathan Vijay; Steven M Haffner
Specific insulin and proinsulin concentrations in nondiabetic South Indians.
Metabolism: clinical and experimental 1998;47(2):230-3.
1998: Sonia S Anand; E A Enas; J Pogue; Steven M Haffner; Thomas A Pearson; S Yusuf
Elevated lipoprotein(a) levels in South Asians in North America.
Metabolism: clinical and experimental 1998;47(2):182-4.
1998: Angela D Liese; Elizabeth J Mayer-Davis; Steven M Haffner
Development of the multiple metabolic syndrome: an epidemiologic perspective.
Epidemiologic reviews 1998;20(2):157-72.
1998: SM Shoff; Polly A Newcomb; J A Mares-Perlman; B E Klein; Steven M Haffner; Barry E Storer; R Klein
Usual consumption of plant foods containing phytoestrogens and sex hormone levels in postmenopausal women in Wisconsin.
Nutrition and cancer 1998;30(3):207-12.
1998: Steven M Haffner
Management of dyslipidemia in adults with diabetes.
Diabetes care 1998;21(1):160-78.
1998: H Miettinen; Seppo Lehto; V Salomaa; Markku Mähönen; M Niemelä; Steven M Haffner; Kalevi Pyörälä; Jaakko Tuomilehto
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.
Diabetes care 1998;21(1):69-75.
1997: David L Rainwater; Braxton D Mitchell; Michael C Mahaney; Steven M Haffner
Genetic relationship between measures of HDL phenotypes and insulin concentrations.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(12):3414-9.
1997: Leena Mykkänen; Steven M Haffner; CN Hales; T Rönnemaa; M Laakso
The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects.
Diabetes 1997;46(12):1990-5.
1997: Ambady Ramachandran; Chamukuttan Snehalatha; Viswanathan Vijay; Kumpatla Satyavani; E Latha; Steven M Haffner
Plasma leptin in non-diabetic Asian Indians: association with abdominal adiposity.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(11):937-41.
1997: L Sanchez-Lugo; Elizabeth J Mayer-Davis; George Howard; J V Selby; M F Ayad; Marian Rewers; Steven M Haffner
Insulin sensitivity and intake of vitamins E and C in African American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Atherosclerosis Study (IRAS).
The American journal of clinical nutrition 1997;66(5):1224-31.
1997: Steven M Haffner; Leena Mykkänen; Michael P Stern
Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy.
American journal of epidemiology 1997;146(7):581-5.
1997: Steven M Haffner
Progress in population analyses of the insulin resistance syndrome.
Annals of the New York Academy of Sciences 1997;827():1-12.
1997: Steven M Haffner
Is there a glycemic threshold?
Archives of internal medicine 1997;157(16):1791.
1997: Leena Mykkänen; Daniel J Zaccaro; Daniel H O'Leary; George Howard; David C Robbins; Steven M Haffner
Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS).
Stroke; a journal of cerebral circulation 1997;28(9):1710-6.
1997: Cashell E Jaquish; John C Blangero; Steven M Haffner; Michael P Stern; Jean W MacCluer
Quantitative genetics of serum sex hormone-binding globulin levels in participants in the San Antonio Family Heart Study.
Metabolism: clinical and experimental 1997;46(9):988-91.
1997: Steven M Haffner; M Hanefeld; S Fischer; K Fuçker; W Leonhardt
Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDM.
Diabetes care 1997;20(9):1430-4.
1997: Jari Töyry; Leo Niskanen; M J Mäntysaari; Esko Länsimies; Steven M Haffner; H J Miettinen; M I J Uusitupa
Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction?: Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects.
Circulation 1997;96(4):1185-91.
1997: Leena Mykkänen; Steven M Haffner; Tapani Rönnemaa; R N Bergman; Markku Laakso
Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors.
American journal of epidemiology 1997;146(4):315-21.
1997: Steven M Haffner; H Miettinen
Insulin resistance implications for type II diabetes mellitus and coronary heart disease.
The American journal of medicine 1997;103(2):152-62.
1997: Steven M Haffner
Impaired glucose tolerance, insulin resistance and cardiovascular disease.
Diabetic medicine : a journal of the British Diabetic Association 1997;14 Suppl 3():S12-8.
1997: S Lehto; T Rönnemaa; Steven M Haffner; K Pyörälä; V Kallio; Markku Laakso
Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.
Diabetes 1997;46(8):1354-9.
1997: Leena Mykkänen; Steven M Haffner; David L Rainwater; Pauli Karhapää; H Miettinen; M Laakso
Relationship of LDL size to insulin sensitivity in normoglycemic men.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(7):1447-53.
1997: Steven M Haffner
Impaired glucose tolerance--is it relevant for cardiovascular disease?
Diabetologia 1997;40 Suppl 2():S138-40.
1997: Steven M Haffner; C Gonzalez; Leena Mykkänen; Michael P Stern
Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study.
Diabetologia 1997;40(7):830-7.
1997: Leo Niskanen; Steven M Haffner; Leila J Karhunen; Anu K Turpeinen; H Miettinen; M I J Uusitupa
Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(1):61-7.
1997: Steven M Haffner; H Miettinen; Michael P Stern
The homeostasis model in the San Antonio Heart Study.
Diabetes care 1997;20(7):1087-92.
1997: Steven M Haffner; H Miettinen; Michael P Stern
Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men.
Diabetologia 1997;40(6):711-7.
1997: Leila J Karhunen; Steven M Haffner; RI Lappalainen; Anu K Turpeinen; H Miettinen; Matti Uusitupa
Serum leptin and short-term regulation of eating in obese women.
Clinical science (London, England : 1979) 1997;92(6):573-8.
1997: Steven M Haffner; H Miettinen; Pauli Karhapää; Leena Mykkänen; M Laakso
Leptin concentrations, sex hormones, and cortisol in nondiabetic men.
The Journal of clinical endocrinology and metabolism 1997;82(6):1807-9.
1997: A Ramachandran; Chamukuttan Snehalatha; Vijay Viswanathan; M Viswanathan; Steven M Haffner
Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites.
Diabetes research and clinical practice 1997;36(2):121-5.
1997: Lynne E Wagenknecht; Ralph D'Agostino; Peter J Savage; Daniel H O'Leary; Mohammed F Saad; Steven M Haffner
Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS).
Stroke; a journal of cerebral circulation 1997;28(5):999-1005.
1997: Steven M Haffner; H Miettinen; Leena Mykkänen; Pauli Karhapää; David L Rainwater; M Laakso
Leptin concentrations and insulin sensitivity in normoglycemic men.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1997;21(5):393-9.
1997: Ma Elena González-Villalpando; Clicerio González-Villalpando; B Arredondo Pérez; S V Martínez Díaz; Braxton D Mitchell; David Rivera-Martínez; R Klein; Steven M Haffner; Michael P Stern
Moderate-to-severe diabetic retinopathy is more prevalent in Mexico City than in San Antonio, Texas.
Diabetes care 1997;20(5):773-7.
1997: Leo Niskanen; Steven M Haffner; Leila J Karhunen; Anu K Turpeinen; H Miettinen; M I J Uusitupa
Serum leptin in relation to resting energy expenditure and fuel metabolism in obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1997;21(4):309-13.
1997: Anu K Turpeinen; Steven M Haffner; Anne Louheranta; Leo Niskanen; H Miettinen; M I J Uusitupa
Serum leptin in subjects with impaired glucose tolerance in relation to insulin sensitivity and first-phase insulin response.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1997;21(4):284-7.
1997: Steven M Haffner
The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
Diabetes care 1997;20(4):469-71.
1997: Sharon L Edelstein; William C Knowler; R P Bain; Reubin Andres; Elizabeth Barrett-Connor; GK Dowse; Steven M Haffner; D J Pettitt; John D Sorkin; Denis C Muller; VR Collins; Richard Hamman
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies.
Diabetes 1997;46(4):701-10.
1997: Steven M Haffner
The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities.
Journal of diabetes and its complications 1997;11(2):69-76.
1997: M Wei; Michael P Stern; Steven M Haffner
Serum leptin levels in Mexican Americans and non-Hispanic whites: association with body mass index and cigarette smoking.
Annals of epidemiology 1997;7(2):81-6.
1997: C Gonzalez Villalpando; D Rivera Martinez; B Arredondo Perez; S Martinez Diaz; M E Gonzalez Villalpando; Steven M Haffner; Michael P Stern
High prevalence of cholelithiasis in a low income Mexican population: an ultrasonographic survey.
Archives of medical research 1997;28(4):543-7.
1997: M Wei; SP Gaskill; Steven M Haffner; Michael P Stern
Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study.
Obesity research 1997;5(1):16-23.
1997: Steven M Haffner
Epidemiology of hypertension and insulin resistance syndrome.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1997;15(1):S25-30.
1997: Steven M Haffner; H Miettinen; Michael P Stern
Are risk factors for conversion to NIDDM similar in high and low risk populations?
Diabetologia 1997;40(1):62-6.
1997: A Laws; H M Hoen; J V Selby; Mohammed F Saad; Steven M Haffner; Barbara V Howard
Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(1):64-71.
1997: Elizabeth J Mayer-Davis; Jane Monaco; H M Hoen; S Carmichael; Mara Z Vitolins; Marian Rewers; Steven M Haffner; M F Ayad; R N Bergman; Andrew J Karter
Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS)
The American journal of clinical nutrition 1997;65(1):79-87.
1997: Steven M Haffner; George Howard; Elizabeth J Mayer-Davis; Richard N Bergman; Peter J Savage; Marian Rewers; Leena Mykkänen; Andrew J Karter; Richard Hamman; Mohammed F Saad
Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.
Diabetes 1997;46(1):63-9.
1996: M Wei; Braxton D Mitchell; Steven M Haffner; Michael P Stern
Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study.
American journal of epidemiology 1996;144(11):1058-65.
1996: H Miettinen; Steven M Haffner; Seppo Lehto; T Rönnemaa; K Pyörälà; Markku Laakso
Retinopathy predicts coronary heart disease events in NIDDM patients.
Diabetes care 1996;19(12):1445-8.
1996: C E Jaquish; John C Blangero; Steven M Haffner; Michael P Stern; Jean W MacCluer
Quantitative genetics of dehydroepiandrosterone sulfate and its relation to possible cardiovascular disease risk factors in Mexican Americans.
Human heredity 1996;46(6):301-9.
1996: M Wei; C Gonzalez; Steven M Haffner; D H O'Leary; Michael P Stern
Ultrasonographically assessed maximum carotid artery wall thickness in Mexico City residents and Mexican Americans living in San Antonio, Texas. Association with diabetes and cardiovascular risk factors.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(11):1388-92.
1996: H Miettinen; Steven M Haffner; Seppo Lehto; T Rönnemaa; Kalevi Pyörälä; Markku Laakso
Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects.
Stroke; a journal of cerebral circulation 1996;27(11):2033-9.
1996: Leo Niskanen; Rainer Rauramaa; H Miettinen; Steven M Haffner; M Mercuri; Matti Uusitupa
Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects.
Stroke; a journal of cerebral circulation 1996;27(11):1986-92.
1996: Andrew J Karter; Elizabeth J Mayer-Davis; Joe V Selby; R B D'Agostino; Steven M Haffner; P Sholinsky; R Bergman; Mohammed F Saad; Richard Hamman
Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.
Diabetes 1996;45(11):1547-55.
1996: Steven M Haffner; R L Gingerich; H Miettinen; Michael P Stern
Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1996;20(10):904-8.
1996: Steven M Haffner; H Miettinen; S P Gaskill; Michael P Stern
Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance.
Diabetologia 1996;39(10):1201-7.
1996: Steven M Haffner; E Kennedy; C Gonzalez; Michael P Stern; H Miettinen
A prospective analysis of the HOMA model. The Mexico City Diabetes Study.
Diabetes care 1996;19(10):1138-41.
1996: Steven M Haffner; S E Moss; B E Klein; R Klein
Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Diabetes care 1996;19(10):1045-50.
1996: Steven M Haffner; M Laakso; H Miettinen; Leena Mykkänen; Pauli Karhapää; David L Rainwater
Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men.
The Journal of clinical endocrinology and metabolism 1996;81(10):3697-701.
1996: Ralph B D'Agostino; G Burke; D O'Leary; Marian Rewers; Joseph Selby; Peter J Savage; Mohammed F Saad; Richard N Bergman; George Howard; Lynne E Wagenknecht; Steven M Haffner
Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study.
Stroke; a journal of cerebral circulation 1996;27(10):1744-9.
1996: Steven M Haffner; H Miettinen; S P Gaskill; Michael P Stern
Metabolic precursors of hypertension. The San Antonio Heart Study.
Archives of internal medicine 1996;156(17):1994-2001.
1996: Steven M Haffner; Michael P Stern; H Miettinen; D Robbins; B V Howard
Apolipoprotein E polymorphism and LDL size in a biethnic population.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(9):1184-8.
1996: Steven M Haffner
Cardiovascular risk factors and the prediabetic syndrome.
Annals of medicine 1996;28(4):363-70.
1996: M Wei; R A Valdez; Braxton D Mitchell; Steven M Haffner; Michael P Stern; Helen Hazuda
Migration status, socioeconomic status, and mortality rates in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study.
Annals of epidemiology 1996;6(4):307-13.
1996: Steven M Haffner; H Miettinen; Michael P Stern; A Agil; Ishwarlal Jialal
Plasma oxidizability in Mexican-Americans and non-Hispanic whites.
Metabolism: clinical and experimental 1996;45(7):876-81.
1996: Steven M Haffner; Michael P Stern; H Miettinen; M Wei; R L Gingerich
Leptin concentrations in diabetic and nondiabetic Mexican-Americans.
Diabetes 1996;45(6):822-4.
1996: Steven M Haffner; Ralph D'Agostino; Mohammed F Saad; Marian Rewers; Leena Mykkänen; Joseph Selby; George Howard; Peter J Savage; Richard Hamman; L E Wagenknecht
Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.
Diabetes 1996;45(6):742-8.
1996: George Howard; Daniel H O'Leary; Daniel J Zaccaro; Steven M Haffner; Marian Rewers; Richard Hamman; Joe V Selby; Mohammed F Saad; P Savage; R Bergman
Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
Circulation 1996;93(10):1809-17.
1996: H Miettinen; Seppo Lehto; P Saikku; Steven M Haffner; T Rönnemaa; Kalevi Pyörälä; M Laakso
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland.
European heart journal 1996;17(5):682-8.
1996: Steven M Haffner; H Miettinen; Michael P Stern
Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes.
The Journal of clinical endocrinology and metabolism 1996;81(5):1846-51.
1996: Steven M Haffner; J Shaten; Michael P Stern; G D Smith; L Kuller
Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial.
American journal of epidemiology 1996;143(9):889-97.
1996: C E Jaquish; Michael C Mahaney; John C Blangero; Steven M Haffner; Michael P Stern; Jean W MacCluer
Genetic correlations between lipoprotein phenotypes and indicators of sex hormone levels in Mexican Americans.
Atherosclerosis 1996;122(1):117-25.
1996: Steven M Haffner
The insulin resistance syndrome revisited.
Diabetes care 1996;19(3):275-7.
1996: Abhimanyu Garg; Steven M Haffner
Insulin resistance and atherosclerosis.
Diabetes care 1996;19(3):274.
1996: L Mykkanen; Steven M Haffner; T Ronnemaa; Richard Watanabe; Markku Laakso
Relationship of plasma insulin concentration and insulin sensitivity to blood pressure. Is it modified by obesity?
Journal of hypertension 1996;14(3):399-405.
1996: Candace M Kammerer; John VandeBerg; Steven M Haffner; J E Hixson
Apolipoprotein B (apo B) signal peptide length polymorphisms are associated with apo B, low density lipoprotein cholesterol, and glucose levels in Mexican Americans.
Atherosclerosis 1996;120(1-2):37-45.
1996: Anthony G Comuzzie; John C Blangero; Michael C Mahaney; Steven M Haffner; Braxton D Mitchell; Michael P Stern; Jean W MacCluer
Genetic and environmental correlations among hormone levels and measures of body fat accumulation and topography.
The Journal of clinical endocrinology and metabolism 1996;81(2):597-600.
1996: Braxton D Mitchell; Candace M Kammerer; Michael C Mahaney; John C Blangero; Anthony G Comuzzie; Larry D Atwood; Steven M Haffner; Michael P Stern; Jean W MacCluer
Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(2):281-8.
1996: D C Robbins; L Andersen; R Bowsher; R Chance; B Dinesen; B Frank; R Gingerich; D Goldstein; H M Widemeyer; Steven M Haffner; C N Hales; L Jarett; Kenneth S Polonsky; D Porte; Jay S Skyler; G Webb; K Gallagher
Report of the American Diabetes Association's Task Force on standardization of the insulin assay.
Diabetes 1996;45(2):242-56.
1996: A Q Galvan; Steven M Haffner; E Ferrannini
Diabetes and hypertension: the scope of the problem.
Blood pressure. Supplement 1996;1():7-9.
1996: Steven M Haffner
Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes.
Hormone research 1996;45(3-5):233-7.
1996: Steven M Haffner
Hypertension in the San Antonio Heart Study and the Mexico City Diabetes Study: clinical and metabolic correlates.
Public health reports (Washington, D.C. : 1974) 1996;111 Suppl 2():11-4.
1996: C Gonzalez Villalpando; Michael P Stern; B Arredondo Perez; S Martinez Diaz; Steven M Haffner
Undiagnosed hypercholesterolemia: a serious health challenge. The Mexico City Diabetes Study.
Archives of medical research 1996;27(1):19-23.
1996: Ele Ferrannini; Elza Muscelli; Michael P Stern; Steven M Haffner
Differential impact of insulin and obesity on cardiovascular risk factors in non-diabetic subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1996;20(1):7-14.
1996: Steven M Haffner; H Miettinen; Michael P Stern
Nondiabetic Mexican-Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites.
Diabetes care 1996;19(1):67-9.
1996: Clicerio González-Villalpando; Michael P Stern; B Arredondo Pérez; S Martĩnez Díaz; Ma Elena González-Villalpando; Steven M Haffner; D Rivera; Andrew Diehl
Prevalence of gallbladder disease and associated clinical variables in a low income population of Mexico City.
Archives of medical research 1996;27(2):237-41.
1995: Steven M Haffner; H Miettinen; S P Gaskill; Michael P Stern
Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.
Diabetes 1995;44(12):1386-91.
1995: Steven M Haffner; C González; H Miettinen; B V Howard; Michael P Stern
LDL size and subclass pattern in Mexico City residents and San Antonio Mexican Americans.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(12):2136-41.
1995: Lynne E Wagenknecht; Elizabeth J Mayer-Davis; Marian Rewers; Steven M Haffner; Joseph Selby; G M Borok; L Henkin; George Howard; Peter J Savage; Mohammed F Saad
The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results.
Annals of epidemiology 1995;5(6):464-72.
1995: Steven M Haffner; Leena Mykkänen; D Robbins; R Valdez; H Miettinen; B V Howard; Michael P Stern; R Bowsher
A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects.
Diabetologia 1995;38(11):1328-36.
1995: A T Singh; David L Rainwater; Steven M Haffner; John VandeBerg; W R Shelledy; P H Moore; Thomas D Dyer
Effect of diabetes on lipoprotein size.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(11):1805-11.
1995: Steven M Haffner; P A Newcomb; P M Marcus; B E Klein; R Klein
Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women.
American journal of epidemiology 1995;142(9):925-34.
1995: Leena Mykkänen; Steven M Haffner; Johanna Kuusisto; Kalevi Pyörälä; C N Hales; Markku Laakso
Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects.
Diabetologia 1995;38(10):1176-82.
1995: Melissa A Austin; L Mykkänen; Johanna Kuusisto; Karen L Edwards; C Nelson; Steven M Haffner; K Pyörälä; Markku Laakso
Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women.
Circulation 1995;92(7):1770-8.
1995: Steven M Haffner; Michael P Stern; H Miettinen; R Gingerich; R R Bowsher
Higher proinsulin and specific insulin are both associated with a parental history of diabetes in nondiabetic Mexican-American subjects.
Diabetes 1995;44(10):1156-60.
1995: R Valdez; Clicerio González-Villalpando; Braxton D Mitchell; Steven M Haffner; Michael P Stern
Differential impact of obesity in related populations.
Obesity research 1995;3 Suppl 2():223s-232s.
1995: Steven M Haffner
Risk factors for non-insulin-dependent diabetes mellitus.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1995;13(2):S73-6.
1995: R Valdez; B V Howard; Michael P Stern; Steven M Haffner
Apolipoprotein E polymorphism and insulin levels in a biethnic population.
Diabetes care 1995;18(7):992-1000.
1995: Steven M Haffner; A Agil; L Mykkanen; Michael P Stern; Ishwarlal Jialal
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Diabetes care 1995;18(5):646-53.
1995: Steven M Haffner; T Orchard; E Stein; D Schmidt; P LaBelle
Effect of simvastatin on Lp(a) concentrations.
Clinical cardiology 1995;18(5):261-7.
1995: P A Newcomb; Ronald Klein; Barbara E K Klein; Steven M Haffner; Julie A Mares-Perlman; K J Cruickshanks; P M Marcus
Association of dietary and life-style factors with sex hormones in postmenopausal women.
Epidemiology (Cambridge, Mass.) 1995;6(3):318-21.
1995: Steven M Haffner; B E Klein; S E Moss; R Klein
Lp(a) is not related to retinopathy in diabetic subjects.
European journal of ophthalmology 1995;5(2):119-23.
1995: A E Monterrosa; Steven M Haffner; Michael P Stern; Helen Hazuda
Sex difference in lifestyle factors predictive of diabetes in Mexican-Americans.
Diabetes care 1995;18(4):448-56.
1995: Braxton D Mitchell; Candace M Kammerer; James E Hixson; Larry D Atwood; S Hackleman; John C Blangero; Steven M Haffner; Michael P Stern; Jean W MacCluer
Evidence for a major gene affecting postchallenge insulin levels in Mexican-Americans.
Diabetes 1995;44(3):284-9.
1995: David L Rainwater; M J Ludwig; Steven M Haffner; John VandeBerg
Lipid and lipoprotein factors associated with variation in Lp(a) density.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(3):313-9.
1995: Steven M Haffner; P Karhapaa; David L Rainwater; L Mykkanen; G Aldrete; M Laakso
Insulin sensitivity and Lp(a) concentrations in normoglycemic men.
Diabetes care 1995;18(2):193-9.
1995: Steven M Haffner; R A Valdez
Endogenous sex hormones: impact on lipids, lipoproteins, and insulin.
The American journal of medicine 1995;98(1A):40S-47S.
1995: Clicerio González-Villalpando; Michael P Stern; Steven M Haffner; B Arredondo Pérez; S Martínez Diaz; S Islas Andrade
The insulin resistance syndrome in Mexico. Prevalence and clinical characteristics: a population based study.
Archives of medical research 1995;26 Spec No():S9-15.
1995: Clicerio González-Villalpando; Michael P Stern; David Rivera-Martínez; B Arredondo Pérez; S Martínez Diaz; Steven M Haffner
Carotid artery atherosclerosis in a Mexico City population with high carbohydrate intake.
Archives of medical research 1995;26(4):409-13.
1995: P H Bennett; Steven M Haffner; B L Kasiske; W F Keane; C E Mogensen; H H Parving; M W Steffes; Gary E Striker
Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;25(1):107-12.
1994: Steven M Haffner; Leena Mykkänen; R A Valdez; Michael P Stern; D L Holloway; A Monterrosa; R R Bowsher
Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome.
The Journal of clinical endocrinology and metabolism 1994;79(6):1806-10.
1994: Steven M Haffner; R R Bowsher; Leena Mykkänen; Helen Hazuda; Braxton D Mitchell; R A Valdez; R Gingerich; A Monterossa; Michael P Stern
Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM.
Diabetes 1994;43(12):1490-3.
1994: L Mykkänen; Johanna Kuusisto; K Pyörälä; Markku Laakso; Steven M Haffner
Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects.
Journal of hypertension 1994;12(12):1425-32.
1994: Steven M Haffner; Leena Mykkänen; Michael P Stern; M Paidi; B V Howard
Greater effect of diabetes on LDL size in women than in men.
Diabetes care 1994;17(10):1164-71.
1994: Steven M Haffner; Clicerio González-Villalpando; Helen Hazuda; R Valdez; L Mykkänen; Michael P Stern
Prevalence of hypertension in Mexico City and San Antonio, Texas.
Circulation 1994;90(3):1542-9.
1994: Steven M Haffner; Leena Mykkänen; R A Valdez; Michael P Stern
Evaluation of two insulin assays in insulin resistance syndrome (syndrome X).
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(9):1430-7.
1994: Leena Mykkänen; T Rönnemaa; J Marniemi; Steven M Haffner; R Bergman; Markku Laakso
Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(8):1264-71.
1994: David L Rainwater; Jean W MacCluer; Michael P Stern; John VandeBerg; Steven M Haffner
Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size.
Diabetes 1994;43(7):942-6.
1994: David Siegel; P Saliba; Steven M Haffner
Glucose and insulin levels during diuretic therapy in hypertensive men.
Hypertension 1994;23(6 Pt 1):688-94.
1994: Steven M Haffner; R A Valdez; Leena Mykkänen; Michael P Stern; Michael S Katz
Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.
Metabolism: clinical and experimental 1994;43(5):599-603.
1994: C Gonzélez; Michael P Stern; Braxton D Mitchell; R A Valdez; Steven M Haffner; B A Pérez
Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
Diabetes care 1994;17(5):397-404.
1994: L Mykkänen; Steven M Haffner; T Rönnemaa; R Bergman; A Leino; Markku Laakso
Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins?
Metabolism: clinical and experimental 1994;43(4):523-8.
1994: Leena Mykkänen; Johanna Kuusisto; Steven M Haffner; Kalevi Pyörälä; Markku Laakso
Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(4):518-26.
1994: L Mykkänen; Steven M Haffner; Johanna Kuusisto; K Pyorälä; Markku Laakso
Microalbuminuria precedes the development of NIDDM.
Diabetes 1994;43(4):552-7.
1994: Steven M Haffner; Pauli Karhapää; Leena Mykkänen; M Laakso
Insulin resistance, body fat distribution, and sex hormones in men.
Diabetes 1994;43(2):212-9.
1994: R Valdez; Braxton D Mitchell; Steven M Haffner; Helen Hazuda; P A Morales; A Monterrosa; Michael P Stern
Predictors of weight change in a bi-ethnic population. The San Antonio Heart Study.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1994;18(2):85-91.
1994: Steven M Haffner; L Mykkanen; K K Gruber; David L Rainwater; M Laakso
Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(1):19-24.
1994: Steven M Haffner; M Frangos; J Williamson; J Santiago; R Valdez; G Aldrete; L Mykkänen; K K Gruber; David L Rainwater
Lp(a) concentrations and phenotypes in children with insulin-dependent diabetes mellitus.
Chemistry and physics of lipids 1994;67-68():223-31.
1994: Clicerio González-Villalpando; Michael P Stern; B Arredondo-Pérez; Braxton D Mitchell; R Valdéz; Steven M Haffner
[Tobacco use in Mexico City].
Salud pública de México 1994;36(1):46-50.
1994: Clicerio González-Villalpando; Michael P Stern; B Arredondo Pérez; R Valdéz; Braxton D Mitchell; Steven M Haffner
Prevalence and detection of hypertension in Mexico.
Archives of medical research 1994;25(3):347-53.
1993: Steven M Haffner; Leena Mykkänen; R A Valdez; Michael S Katz
Relationship of sex hormones to lipids and lipoproteins in nondiabetic men.
The Journal of clinical endocrinology and metabolism 1993;77(6):1610-5.
1993: Steven M Haffner; R Klein; S E Moss; B E Klein
Sex hormones and the incidence of severe retinopathy in male subjects with type I diabetes.
Ophthalmology 1993;100(12):1782-6.
1993: Steven M Haffner; R A Valdez; Michael P Stern; Michael S Katz
Obesity, body fat distribution and sex hormones in men.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1993;17(11):643-9.
1993: Steven M Haffner; Leena Mykkänen; R A Valdez; M Paidi; Michael P Stern; B V Howard
LDL size and subclass pattern in a biethnic population.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(11):1623-30.
1993: Steven M Haffner; C Gonzales; R A Valdez; Leena Mykkänen; Helen Hazuda; Braxton D Mitchell; A Monterrosa; Michael P Stern
Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study.
Diabetologia 1993;36(10):1002-6.
1993: Barbara V Howard; Neil Schneiderman; B Falkner; Steven M Haffner; A Laws
Insulin, health behaviors, and lipid metabolism.
Metabolism: clinical and experimental 1993;42(9 Suppl 1):25-35.
1993: Steven M Haffner; Andrew Diehl; R Valdez; Braxton D Mitchell; Helen Hazuda; P Morales; Michael P Stern
Clinical gallbladder disease in NIDDM subjects. Relationship to duration of diabetes and severity of glycemia.
Diabetes care 1993;16(9):1276-84.
1993: Braxton D Mitchell; R Valdez; Helen Hazuda; Steven M Haffner; A Monterrosa; Michael P Stern
Differences in the prevalence of diabetes and impaired glucose tolerance according to maternal or paternal history of diabetes.
Diabetes care 1993;16(9):1262-7.
1993: Steven M Haffner; Leena Mykkänen; Michael P Stern; R A Valdez; J A Heisserman; R R Bowsher
Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects.
Diabetes 1993;42(9):1297-302.
1993: Michael P Stern; R A Valdez; Steven M Haffner; Braxton D Mitchell; Helen Hazuda
Stability over time of modern diagnostic criteria for type II diabetes.
Diabetes care 1993;16(7):978-83.
1993: Steven M Haffner; R A Valdez; P A Morales; Helen Hazuda; Michael P Stern
Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men.
The Journal of clinical endocrinology and metabolism 1993;77(1):56-60.
1993: Steven M Haffner; R L Bauer
The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women.
Metabolism: clinical and experimental 1993;42(6):735-8.
1993: Steven M Haffner
Lipoprotein(a) and diabetes. An update.
Diabetes care 1993;16(5):835-40.
1993: Michael P Stern; P A Morales; R A Valdez; A Monterrosa; Steven M Haffner; Braxton D Mitchell; Helen Hazuda
Predicting diabetes. Moving beyond impaired glucose tolerance.
Diabetes 1993;42(5):706-14.
1993: Michael P Stern; C Gonzalez; M Hernandex; J A Knapp; Helen Hazuda; E Villapando; R A Valdez; Steven M Haffner; Braxton D Mitchell
Performance of semiquantitative food frequency questionnaires in international comparisons. Mexico City versus San Antonio, Texas.
Annals of epidemiology 1993;3(3):300-7.
1993: Steven M Haffner
Insulin and blood pressure: fact or fantasy?
The Journal of clinical endocrinology and metabolism 1993;76(3):541-3.
1993: Clicerio González-Villalpando; Michael P Stern; R Valdez; Braxton D Mitchell; Steven M Haffner
[Blood lipid levels and atherogenic risk in an open urban population].
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1993;45(2):127-32.
1993: Steven M Haffner; P A Morales; M K Gruber; Helen Hazuda; Michael P Stern
Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(2):205-10.
1993: Braxton D Mitchell; Sarah Williams-Blangero; R Chakraborty; R Valdez; Helen Hazuda; Steven M Haffner; Michael P Stern
A comparison of three methods for assessing Amerindian admixture in Mexican Americans.
Ethnicity & disease 1993;3(1):22-31.
1993: P A Morales; Braxton D Mitchell; R A Valdez; Helen Hazuda; Michael P Stern; Steven M Haffner
Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study.
Diabetes 1993;42(1):154-61.
1993: Steven M Haffner; P A Morales; Helen Hazuda; Michael P Stern
Level of control of hypertension in Mexican Americans and non-Hispanic whites.
Hypertension 1993;21(1):83-8.
1993: Steven M Haffner; Braxton D Mitchell; S E Moss; Michael P Stern; Helen Hazuda; J Patterson; Wichard A J van Heuven; R Klein
Is there an ethnic difference in the effect of risk factors for diabetic retinopathy?
Annals of epidemiology 1993;3(1):2-8.
1992: Michael P Stern; P A Morales; Steven M Haffner; R A Valdez
Hyperdynamic circulation and the insulin resistance syndrome ("syndrome X").
Hypertension 1992;20(6):802-8.
1992: G Gulli; E Ferrannini; Michael P Stern; Steven M Haffner; Ralph DeFronzo
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents.
Diabetes 1992;41(12):1575-86.
1992: Steven M Haffner; K K Gruber; G Aldrete; P A Morales; Michael P Stern; K R Tuttle
Increased lipoprotein(a) concentrations in chronic renal failure.
Journal of the American Society of Nephrology : JASN 1992;3(5):1156-62.
1992: Steven M Haffner; K K Gruber; P A Morales; Helen Hazuda; R A Valdez; Braxton D Mitchell; Michael P Stern
Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study.
American journal of epidemiology 1992;136(9):1060-8.
1992: Steven M Haffner; R L Bauer
Excess androgenicity only partially explains the relationship between obesity and bone density in premenopausal women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1992;16(11):869-74.
1992: Steven M Haffner; R Valdez; P A Morales; Braxton D Mitchell; Helen Hazuda; Michael P Stern
Greater effect of glycemia on incidence of hypertension in women than in men.
Diabetes care 1992;15(10):1277-84.
1992: Steven M Haffner; P A Morales; Michael P Stern; M K Gruber
Lp(a) concentrations in NIDDM.
Diabetes 1992;41(10):1267-72.
1992: Steven M Haffner; E Ferrannini; Helen Hazuda; Michael P Stern
Clustering of cardiovascular risk factors in confirmed prehypertensive individuals.
Hypertension 1992;20(1):38-45.
1992: Clicerio González-Villalpando; Michael P Stern; E Villalpando; Helen Hazuda; Steven M Haffner; E Lisci
[Prevalence of diabetes and glucose intolerance in a urban population at a low economic level].
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1992;44(3):321-8.
1992: Braxton D Mitchell; Steven M Haffner; Helen Hazuda; R Valdez; Michael P Stern
The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels.
American journal of epidemiology 1992;136(1):12-22.
1992: Steven M Haffner; R A Valdez; Helen Hazuda; Braxton D Mitchell; P A Morales; Michael P Stern
Prospective analysis of the insulin-resistance syndrome (syndrome X).
Diabetes 1992;41(6):715-22.
1992: Michael P Stern; Braxton D Mitchell; Steven M Haffner; Helen Hazuda
Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia? A community perspective.
Diabetes care 1992;15(5):638-44.
1992: Michael P Stern; C Gonzalez; Braxton D Mitchell; E Villalpando; Steven M Haffner; Helen Hazuda
Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio.
Diabetes 1992;41(4):484-92.
1992: E Ferrannini; Michael P Stern; A Q Galvan; Braxton D Mitchell; Steven M Haffner
Impact of associated conditions on glycemic control of NIDDM patients.
Diabetes care 1992;15(4):508-14.
1992: Steven M Haffner; Michael P Stern; Richard Watanabe; R N Bergman
Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans.
European journal of clinical investigation 1992;22(3):147-53.
1992: Steven M Haffner; Braxton D Mitchell; R A Valdez; Helen Hazuda; P A Morales; Michael P Stern
Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study.
American journal of hypertension 1992;5(3):147-53.
1992: Steven M Haffner; J F Dunn; M S Katz
Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women.
Metabolism: clinical and experimental 1992;41(3):278-84.
1992: Steven M Haffner; R S Kushwaha; W R Hazzard
Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
Metabolism: clinical and experimental 1992;41(3):241-5.
1992: Steven M Haffner; Braxton D Mitchell; Michael P Stern; Helen Hazuda; J K Patterson
Public health significance of upper body adiposity for non-insulin dependent diabetes mellitus in Mexican Americans.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1992;16(3):177-84.
1992: Steven M Haffner; S E Moss; B E Klein; R Klein
Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Metabolism: clinical and experimental 1992;41(2):194-7.
1992: Steven M Haffner; K R Tuttle; David L Rainwater
Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes.
Metabolism: clinical and experimental 1992;41(2):116-20.
1992: Braxton D Mitchell; Steven M Haffner; Helen Hazuda; J K Patterson; Michael P Stern
Diabetes and coronary heart disease risk in Mexican Americans.
Annals of epidemiology 1992;2(1-2):101-6.
1991: Michael P Stern; Steven M Haffner
Dyslipidemia in type II diabetes. Implications for therapeutic intervention.
Diabetes care 1991;14(12):1144-59.
1991: Steven M Haffner
Compositional changes in lipoproteins of subjects with non-insulin-dependent diabetes mellitus.
The Journal of laboratory and clinical medicine 1991;118(2):109-10.
1991: Braxton D Mitchell; Helen Hazuda; Steven M Haffner; J K Patterson; Michael P Stern
High prevalence of angina pectoris in Mexican-American men. A population with reduced risk of myocardial infarction.
Annals of epidemiology 1991;1(5):415-26.
1991: Steven M Haffner; Braxton D Mitchell; Michael P Stern; Helen Hazuda
Macrovascular complications in Mexican Americans with type II diabetes.
Diabetes care 1991;14(7):665-71.
1991: Michael P Stern; J A Knapp; Helen Hazuda; Steven M Haffner; J K Patterson; Braxton D Mitchell
Genetic and environmental determinants of type II diabetes in Mexican Americans. Is there a "descending limb" to the modernization/diabetes relationship?
Diabetes care 1991;14(7):649-54.
1991: Steven M Haffner; Michael S Katz; J F Dunn
Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women.
International journal of obesity 1991;15(7):471-8.
1991: Steven M Haffner; Michael P Stern; Braxton D Mitchell; Helen Hazuda
Predictors of obesity in Mexican Americans.
The American journal of clinical nutrition 1991;53(6 Suppl):1571S-1576S.
1991: Helen Hazuda; Braxton D Mitchell; Steven M Haffner; Michael P Stern
Obesity in Mexican American subgroups: findings from the San Antonio Heart Study.
The American journal of clinical nutrition 1991;53(6 Suppl):1529S-1534S.
1991: E Ferrannini; Steven M Haffner; Michael P Stern; Braxton D Mitchell; A Natali; Helen Hazuda; J K Patterson
High blood pressure and insulin resistance: influence of ethnic background.
European journal of clinical investigation 1991;21(3):280-7.
1991: E Ferrannini; Steven M Haffner; Braxton D Mitchell; Michael P Stern
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
Diabetologia 1991;34(6):416-22.
1991: Steven M Haffner; Braxton D Mitchell; Helen Hazuda; Michael P Stern
Greater influence of central distribution of adipose tissue on incidence of non-insulin-dependent diabetes in women than men.
The American journal of clinical nutrition 1991;53(5):1312-7.
1991: Steven M Haffner; K R Tuttle; David L Rainwater
Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects.
Diabetes care 1991;14(4):302-7.
1991: Steven M Haffner; Helen Hazuda; Braxton D Mitchell; J K Patterson; Michael P Stern
Increased incidence of type II diabetes mellitus in Mexican Americans.
Diabetes care 1991;14(2):102-8.
1991: Braxton D Mitchell; Helen Hazuda; Steven M Haffner; J K Patterson; Michael P Stern
Myocardial infarction in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study.
Circulation 1991;83(1):45-51.
1990: Ele Ferrannini; Steven M Haffner; Michael P Stern
Insulin sensitivity and hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(7):S169-74.
1990: Steven M Haffner; R Klein; J F Dunn; S E Moss; B E Klein
Increased testosterone in type I diabetic subjects with severe retinopathy.
Ophthalmology 1990;97(10):1270-4.
1990: Steven M Haffner; Michael P Stern; M K Gruber; Helen Hazuda; Braxton D Mitchell; J K Patterson
Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?
Arteriosclerosis (Dallas, Tex.) 1990;10(5):727-31.
1990: Steven M Haffner; Braxton D Mitchell; Michael P Stern; Helen Hazuda; J K Patterson
Decreased prevalence of hypertension in Mexican-Americans.
Hypertension 1990;16(3):225-32; discussion 233-4.
1990: Steven M Haffner; Michael P Stern; J Dunn; M Mobley; J Blackwell; Richard N Bergman
Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans.
Metabolism: clinical and experimental 1990;39(8):842-7.
1990: Steven M Haffner; Andrew Diehl; Braxton D Mitchell; Michael P Stern; Helen Hazuda
Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus.
American journal of epidemiology 1990;132(2):327-35.
1990: Michael P Stern; J K Patterson; Braxton D Mitchell; Steven M Haffner; Helen Hazuda
Overweight and mortality in Mexican Americans.
International journal of obesity 1990;14(7):623-9.
1990: Steven M Haffner; Michael P Stern; Helen Hazuda; Braxton D Mitchell; J K Patterson
Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
JAMA : the journal of the American Medical Association 1990;263(21):2893-8.
1990: Steven M Haffner; Michael P Stern; Braxton D Mitchell; Helen Hazuda; J K Patterson
Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.
Diabetes 1990;39(3):283-8.
1990: Braxton D Mitchell; Michael P Stern; Steven M Haffner; Helen Hazuda; J K Patterson
Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study.
American journal of epidemiology 1990;131(3):423-33.
1990: Michael P Stern; Steven M Haffner
Type II diabetes and its complications in Mexican Americans.
Diabetes/metabolism reviews 1990;6(1):29-45.
1990: Braxton D Mitchell; Michael P Stern; Steven M Haffner; Helen Hazuda; J K Patterson
Functional impairment in Mexican Americans and non-Hispanic whites with diabetes.
Journal of clinical epidemiology 1990;43(4):319-27.
1990: Steven M Haffner; Michael S Katz; J F Dunn
The relationship of insulin sensitivity and metabolic clearance of insulin to adiposity and sex hormone binding globulin.
Endocrine research 1990;16(3):361-76.
1990: Ele Ferrannini; Steven M Haffner; Michael P Stern
Essential hypertension: an insulin-resistant state.
Journal of cardiovascular pharmacology 1990;15 Suppl 5():S18-25.
1989: Andrew Diehl; Steven M Haffner; J A Knapp; Helen Hazuda; Michael P Stern
Dietary intake and the prevalence of gallbladder disease in Mexican Americans.
Gastroenterology 1989;97(6):1527-33.
1989: Steven M Haffner; Michael P Stern; Helen Hazuda; Braxton D Mitchell; J K Patterson; E Ferrannini
Parental history of diabetes is associated with increased cardiovascular risk factors.
Arteriosclerosis (Dallas, Tex.) 1989;9(6):928-33.
1989: Steven M Haffner; R S Kushwaha; William R Hazzard
Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia).
European journal of clinical investigation 1989;19(5):486-90.
1989: Steven M Haffner; Braxton D Mitchell; Jacqueline A Pugh; Michael P Stern; M K Kozlowski; Helen Hazuda; J K Patterson; R Klein
Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM.
Diabetes care 1989;12(8):530-6.
1989: S H Raboudi; Braxton D Mitchell; Michael P Stern; C W Eifler; Steven M Haffner; Helen Hazuda; Marsha L Frazier
Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans.
Diabetes 1989;38(8):975-80.
1989: Michael P Stern; J K Patterson; Steven M Haffner; Helen Hazuda; Braxton D Mitchell
Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey.
JAMA : the journal of the American Medical Association 1989;262(3):360-4.
1989: Steven M Haffner; Andrew Diehl; Michael P Stern; Helen Hazuda
Central adiposity and gallbladder disease in Mexican Americans.
American journal of epidemiology 1989;129(3):587-95.
1989: Steven M Haffner; Helen Hazuda; Michael P Stern; J K Patterson; Wichard A J van Heuven; D Fong
Effects of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM.
Diabetes care 1989;12(2):128-34.
1989: Steven M Haffner; Michael S Katz; Michael P Stern; J F Dunn
Relationship of sex hormone binding globulin to overall adiposity and body fat distribution in a biethnic population.
International journal of obesity 1989;13(1):1-9.
1989: Steven M Haffner; M S Katz; Michael P Stern; J F Dunn
Association of decreased sex hormone binding globulin and cardiovascular risk factors.
Arteriosclerosis (Dallas, Tex.) 1989;9(1):136-43.
1988: Helen Hazuda; Steven M Haffner; Michael P Stern; C W Eifler
Effects of acculturation and socioeconomic status on obesity and diabetes in Mexican Americans. The San Antonio Heart Study.
American journal of epidemiology 1988;128(6):1289-301.
1988: Michael P Stern; Steven M Haffner
Prospective assessment of metabolic control in diabetes mellitus: the complications question.
JAMA : the journal of the American Medical Association 1988;260(19):2896-7.
1988: Steven M Haffner; Michael P Stern; Helen Hazuda; Braxton D Mitchell; J K Patterson
Increased insulin concentrations in nondiabetic offspring of diabetic parents.
The New England journal of medicine 1988;319(20):1297-301.
1988: Jacqueline A Pugh; Michael P Stern; Steven M Haffner; Helen Hazuda; J Patterson
Detection and treatment of hypercholesterolemia in a biethnic community, 1979-1985.
Journal of general internal medicine 1988;3(4):331-6.
1988: Steven M Haffner; D Fong; Michael P Stern; Jacqueline A Pugh; Helen Hazuda; J K Patterson; Wichard A J van Heuven; R Klein
Diabetic retinopathy in Mexican Americans and non-Hispanic whites.
Diabetes 1988;37(7):878-84.
1988: Steven M Haffner; Michael S Katz; Michael P Stern; J F Dunn
The relationship of sex hormones to hyperinsulinemia and hyperglycemia.
Metabolism: clinical and experimental 1988;37(7):683-8.
1988: Steven M Haffner; D Fong; Helen Hazuda; Jacqueline A Pugh; J K Patterson
Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics.
Metabolism: clinical and experimental 1988;37(4):338-45.
1988: J A Knapp; Helen Hazuda; Steven M Haffner; E A Young; Michael P Stern
A saturated fat/cholesterol avoidance scale: sex and ethnic differences in a biethnic population.
Journal of the American Dietetic Association 1988;88(2):172-7.
1988: Jacqueline A Pugh; Michael P Stern; Steven M Haffner; C W Eifler; M Zapata
Excess incidence of treatment of end-stage renal disease in Mexican Americans.
American journal of epidemiology 1988;127(1):135-44.
1988: Michael P Stern; Steven M Haffner
Do anthropometric differences between Mexican Americans and non-Hispanic whites explain ethnic differences in metabolic variables?
Acta medica Scandinavica. Supplementum 1988;723():37-44.
1987: D Applebaum-Bowden; Steven M Haffner; William R Hazzard
The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol.
Metabolism: clinical and experimental 1987;36(10):949-52.
1987: Andrew Diehl; Steven M Haffner; Helen Hazuda; Michael P Stern
Coronary risk factors and clinical gallbladder disease: an approach to the prevention of gallstones?
American journal of public health 1987;77(7):841-5.
1987: Steven M Haffner
Hyperinsulinemia as a possible etiology for the high prevalence of non insulin dependent diabetes in Mexican Americans.
Diabète & métabolisme 1987;13(3 Pt 2):337-44.
1987: Steven M Haffner; Michael P Stern; Helen Hazuda; J Pugh; J K Patterson
Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non-insulin-dependent diabetes mellitus, lipids, and lipoproteins.
Diabetes 1987;36(1):43-51.
1986: Steven M Haffner; Michael P Stern; Helen Hazuda; Jacqueline A Pugh; J K Patterson
Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus.
The New England journal of medicine 1986;315(4):220-4.
1986: Steven M Haffner; Michael P Stern; Helen Hazuda; M Rosenthal; J A Knapp
The role of behavioral variables and fat patterning in explaining ethnic differences in serum lipids and lipoproteins.
American journal of epidemiology 1986;123(5):830-9.
1986: Helen Hazuda; Steven M Haffner; Michael P Stern; J A Knapp; C W Eifler; M Rosenthal
Employment status and women's protection against coronary heart disease. Findings from the San Antonio Heart Study.
American journal of epidemiology 1986;123(4):623-40.
1986: Michael P Stern; R E Ferrell; M Rosenthal; Steven M Haffner; Helen Hazuda
Association between NIDDM, RH blood group, and haptoglobin phenotype. Results from the San Antonio Heart Study.
Diabetes 1986;35(4):387-91.
1986: Steven M Haffner; Michael P Stern; Helen Hazuda; M Rosenthal; J A Knapp; R M Malina
Role of obesity and fat distribution in non-insulin-dependent diabetes mellitus in Mexican Americans and non-Hispanic whites.
Diabetes care 1986;9(2):153-61.
1986: Michael P Stern; Steven M Haffner
Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease.
Arteriosclerosis (Dallas, Tex.) 1986;6(2):123-30.
1986: Helen Hazuda; P J Comeaux; Michael P Stern; Steven M Haffner; C W Eifler; M Rosenthal
A comparison of three indicators for identifying Mexican Americans in epidemiologic research. Methodological findings from the San Antonio Heart Study.
American journal of epidemiology 1986;123(1):96-112.
1986: Steven M Haffner; Michael P Stern; Helen Hazuda; J Pugh; J K Patterson; R Malina
Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables.
International journal of obesity 1986;10(6):493-502.
1986: R Chakraborty; R E Ferrell; Michael P Stern; Steven M Haffner; Helen Hazuda; M Rosenthal
Relationship of prevalence of non-insulin-dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas.
Genetic epidemiology 1986;3(6):435-54.
1985: Steven M Haffner; J A Knapp; Helen Hazuda; Michael P Stern; E A Young
Dietary intakes of macronutrients among Mexican Americans and Anglo Americans: the San Antonio heart study.
The American journal of clinical nutrition 1985;42(6):1266-75.
1985: Rampratap S Kushwaha; Steven M Haffner; David M Foster; William R Hazzard
Compositional and metabolic heterogeneity of alpha 2- and beta-very-low-density lipoproteins in subjects with broad beta disease and endogenous hypertriglyceridemia.
Metabolism: clinical and experimental 1985;34(11):1029-38.
1985: J A Knapp; Steven M Haffner; E A Young; Helen Hazuda; L Gardner; Michael P Stern
Dietary intakes of essential nutrients among Mexican-Americans and Anglo-Americans: the San Antonio Heart Study.
The American journal of clinical nutrition 1985;42(2):307-16.
1985: Michael P Stern; M Rosenthal; Steven M Haffner
A new concept of impaired glucose tolerance. Relation to cardiovascular risk.
Arteriosclerosis (Dallas, Tex.) 1985;5(4):311-4.
1985: Steven M Haffner; J A Knapp; Michael P Stern; Helen Hazuda; M Rosenthal; L J Franco
Coffee consumption, diet, and lipids.
American journal of epidemiology 1985;122(1):1-12.
1985: L J Franco; Michael P Stern; M Rosenthal; Steven M Haffner; Helen Hazuda; P J Comeaux
Prevalence, detection, and control of hypertension in a biethnic community. The San Antonio Heart Study.
American journal of epidemiology 1985;121(5):684-96.
1985: D Applebaum-Bowden; Steven M Haffner; P W Wahl; J J Hoover; G. Russell Warnick; John J Albers; William R Hazzard
Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol.
Arteriosclerosis (Dallas, Tex.) 1985;5(3):273-82.
1985: Steven M Haffner; D Applebaum-Bowden; P W Wahl; J J Hoover; G. Russell Warnick; John J Albers; William R Hazzard
Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity.
Arteriosclerosis (Dallas, Tex.) 1985;5(2):169-77.
1985: M Rosenthal; C A McMahan; Michael P Stern; C W Eifler; Steven M Haffner; Helen Hazuda; L J Franco
Evidence of bimodality of two hour plasma glucose concentrations in Mexican Americans: results from the San Antonio Heart study.
Journal of chronic diseases 1985;38(1):5-16.
1984: Michael P Stern; M Rosenthal; Steven M Haffner; Helen Hazuda; L J Franco
Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans. The San Antonio Heart Study.
American journal of epidemiology 1984;120(6):834-51.
1984: William R Hazzard; Rampratap S Kushwaha; D Applebaum-Bowden; Steven M Haffner; A Steinmetz; David M Foster
Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.
Metabolism: clinical and experimental 1984;33(10):873-81.
1984: John J Albers; H M Taggart; D Applebaum-Bowden; Steven M Haffner; C H Chesnut; William R Hazzard
Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol.
Biochimica et biophysica acta 1984;795(2):293-6.
1984: William R Hazzard; Steven M Haffner; Rampratap S Kushwaha; D Applebaum-Bowden; David M Foster
Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.
Metabolism: clinical and experimental 1984;33(9):779-84.
1984: Steven M Haffner; M Rosenthal; Helen Hazuda; Michael P Stern; L J Franco
Evaluation of three potential screening tests for diabetes mellitus in a biethnic population.
Diabetes care 1984;7(4):347-53.
1984: Steven M Haffner; David M Foster; Rampratap S Kushwaha; William R Hazzard
Retarded chylomicron apolipoprotein-B catabolism in type 2 (non-insulin-dependent) diabetic subjects with lipaemia.
Diabetologia 1984;26(5):349-54.
1984: D Applebaum-Bowden; Steven M Haffner; E Hartsook; K H Luk; J J Albers; William R Hazzard
Down-regulation of the low-density lipoprotein receptor by dietary cholesterol.
The American journal of clinical nutrition 1984;39(3):360-7.
1984: L I Gardner; Michael P Stern; Steven M Haffner; S P Gaskill; Helen Hazuda; J H Relethford; C W Eifler
Prevalence of diabetes in Mexican Americans. Relationship to percent of gene pool derived from native American sources.
Diabetes 1984;33(1):86-92.
1983: Helen Hazuda; Michael P Stern; S P Gaskill; Steven M Haffner; L I Gardner
Ethnic differences in health knowledge and behaviors related to the prevention and treatment of coronary heart disease. The San Antonio Heart Study.
American journal of epidemiology 1983;117(6):717-28.
1983: Michael P Stern; S P Gaskill; Helen Hazuda; L I Gardner; Steven M Haffner
Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study.
Diabetologia 1983;24(4):272-7.
1983: Steven M Haffner; Rampratap S Kushwaha; David M Foster; D Applebaum-Bowden; William R Hazzard
Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy.
Metabolism: clinical and experimental 1983;32(4):413-20.
1982: H M Taggart; D Applebaum-Bowden; Steven M Haffner; G. Russell Warnick; M C Cheung; John J Albers; C H Chestnut; William R Hazzard
Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis.
Metabolism: clinical and experimental 1982;31(11):1147-52.
1981: Rampratap S Kushwaha; Steven M Haffner; David M Foster; William R Hazzard
Catabolism of alpha2-and beta-very low density lipoproteins in normal and hyperlipidemic subjects.
Transactions of the Association of American Physicians 1981;94():253-60.